[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 265
1. Masamoto Y, Nannya Y, Arai S, Koike Y, Hangaishi A, Yatomi Y, Kurokawa M: Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy. Br J Haematol; 2009 Mar;144(5):798-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Arsenicals / therapeutic use. Basophils / pathology. Leukemia, Promyelocytic, Acute / pathology. Oxides / therapeutic use

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. ARSENIC TRIOXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19036092.001).
  • [ISSN] 1365-2141
  • [Journal-full-title] British journal of haematology
  • [ISO-abbreviation] Br. J. Haematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Arsenicals; 0 / Oxides; S7V92P67HO / arsenic trioxide
  •  go-up   go-down


2. Gill RM, Etzell JE: Basophilic leukemia in recurrent chronic myelogenous leukemia blast phase. Am J Hematol; 2007 Aug;82(8):736-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basophilic leukemia in recurrent chronic myelogenous leukemia blast phase.
  • [MeSH-major] Blast Crisis / pathology. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology

  • MedlinePlus Health Information. consumer health - Chronic Myeloid Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17492647.001).
  • [ISSN] 0361-8609
  • [Journal-full-title] American journal of hematology
  • [ISO-abbreviation] Am. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Carriero MV, Longanesi-Cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, Votta G, Masucci MT, Arra C, Franco R, De Rosa M, Stoppelli MP, Pavone V: Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis. Mol Cancer Ther; 2009 Sep;8(9):2708-17
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fluorescein-RERF associates with very high affinity to RBL-2H3 rat basophilic leukemia cells expressing the human formyl peptide receptor (FPR).

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19706734.001).
  • [ISSN] 1538-8514
  • [Journal-full-title] Molecular cancer therapeutics
  • [ISO-abbreviation] Mol. Cancer Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Peptide Fragments; 0 / Receptors, Urokinase Plasminogen Activator
  •  go-up   go-down


Advertisement
4. Nasser MW, Raghuwanshi SK, Malloy KM, Gangavarapu P, Shim JY, Rajarathnam K, Richardson RM: CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization. J Biol Chem; 2007 Mar 2;282(9):6906-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The receptors were stably expressed in rat basophilic leukemia 2H3 cells and characterized for receptor binding, intracellular Ca(2+) mobilization, phosphoinositide hydrolysis, phosphorylation, internalization, and MAPK activation.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-ASPARTIC ACID .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17204468.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI069152; United States / NIAID NIH HHS / AI / AI-069152; United States / NIAID NIH HHS / AI / AI-38910
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Interleukin-8; 0 / Receptors, Interleukin-8A; 0 / Receptors, Interleukin-8B; 30KYC7MIAI / Aspartic Acid
  •  go-up   go-down


5. Ljubić N, Lang N, Skelin IK, Lasan R, Dominis M, Perković L, Zupanić-Krmek D, Grgurević-Batinica A: Klinefelter syndrome and acute basophilic leukaemia--case report. Coll Antropol; 2010 Jun;34(2):657-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Klinefelter syndrome and acute basophilic leukaemia--case report.
  • Patients with 47, XXY karyotype (Klinefelter syndrome) appear to have increased risk of developing cancer, especially male breast cancer, germ cell tumours and non Hodgkin lymphomas, but rarely acute myeloid leukaemia.
  • We report a patient with acute basophilic leukaemia with 47, XXY karyotype in both the tumour and constitutional cells.
  • Acute basophilic leukaemia is very rare disease comprising less than 1% of all acute myeloid leukaemias.
  • Morphological characteristic of leukaemic blast cells is moderately basophilic cytoplasm containing a variable number of coarse basophilic granules.
  • There is no consistent chromosomal abnormality identified in this leukaemia.
  • This is the first reported case of acute basophilic leukaemia in patient with Klinefelter syndrome.
  • In this article the medical history of the patient is given and the possible connection between Klinefelter syndrome and acute myeloid leukaemia is discussed.
  • [MeSH-major] Klinefelter Syndrome / complications. Leukemia, Basophilic, Acute / complications

  • Genetic Alliance. consumer health - Klinefelter syndrome.
  • MedlinePlus Health Information. consumer health - Klinefelter's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698148.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


6. Huang YF, Liu H, Xiong X, Chen Y, Tan W: Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells. J Am Chem Soc; 2009 Dec 2;131(47):17328-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found that both nanoparticle size and surface ligand density play key regulatory roles in the process of membrane antibody-receptor (IgE-Fc epsilonRI) binding and cross-linking, which, in turn, leads to degranulation and consequent release of chemical mediators on rat basophilic leukemia cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol. 2002 Jul 15;169(2):856-64 [12097389.001]
  • [Cites] Chemistry. 2009;15(21):5327-36 [19360825.001]
  • [Cites] Biochemistry. 2003 Nov 11;42(44):12739-48 [14596588.001]
  • [Cites] Anal Chem. 2004 Jul 1;76(13):3727-34 [15228347.001]
  • [Cites] Proc Natl Acad Sci U S A. 1973 Dec;70(12):3305-10 [4519624.001]
  • [Cites] J Immunol. 1979 Jun;122(6):2150-3 [448121.001]
  • [Cites] J Immunol. 1979 Oct;123(4):1445-50 [479592.001]
  • [Cites] J Immunol. 1980 Aug;125(2):701-10 [7391576.001]
  • [Cites] Eur J Immunol. 1981 Apr;11(4):317-23 [6166481.001]
  • [Cites] Mol Immunol. 1986 Jul;23(7):783-90 [2948111.001]
  • [Cites] Biophys J. 1987 Oct;52(4):657-62 [2960385.001]
  • [Cites] EMBO J. 1988 Dec 20;7(13):4101-9 [2977332.001]
  • [Cites] J Immunol. 1992 Sep 1;149(5):1477-87 [1324276.001]
  • [Cites] Mol Immunol. 1994 Feb;31(3):169-217 [8114766.001]
  • [Cites] Annu Rev Immunol. 1999;17:931-72 [10358778.001]
  • [Cites] Immunol Lett. 1999 May 3;68(1):59-69 [10397157.001]
  • [Cites] Biosens Bioelectron. 2004 Nov 1;20(4):791-6 [15522594.001]
  • [Cites] Anal Chem. 2006 Mar 1;78(5):1485-93 [16503598.001]
  • [Cites] Angew Chem Int Ed Engl. 2006 Apr 3;45(15):2348-68 [16557636.001]
  • [Cites] Anal Chem. 2006 Dec 15;78(24):8313-8 [17165821.001]
  • [Cites] Anal Chem. 2006 Dec 15;78(24):8332-8 [17165824.001]
  • [Cites] Org Lett. 2007 Aug 30;9(18):3551-4 [17691795.001]
  • [Cites] ACS Chem Biol. 2007 Oct 19;2(10):674-84 [18041817.001]
  • [Cites] Biochemistry. 2008 Jan 22;47(3):1017-30 [18154361.001]
  • [Cites] Nat Nanotechnol. 2008 Jan;3(1):36-40 [18654448.001]
  • [Cites] Nat Nanotechnol. 2008 Mar;3(3):145-50 [18654486.001]
  • [Cites] J Am Chem Soc. 2002 Aug 14;124(32):9606-12 [12167056.001]
  • (PMID = 19929020.001).
  • [ISSN] 1520-5126
  • [Journal-full-title] Journal of the American Chemical Society
  • [ISO-abbreviation] J. Am. Chem. Soc.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM079359; United States / NIGMS NIH HHS / GM / R01 GM079359-01; None / None / / R01 GM079359-01; United States / NIGMS NIH HHS / GM / R01 GM079359-02; United States / NIGMS NIH HHS / GM / R01 GM079359-03; None / None / / R01 GM079359-02; None / None / / R01 GM079359-01S1; United States / NIGMS NIH HHS / GM / R01 GM079359-01S1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, IgE
  • [Other-IDs] NLM/ NIHMS158340; NLM/ PMC2786779
  •  go-up   go-down


7. Harata G, He F, Takahashi K, Hosono A, Kawase M, Kubota A, Hiramatsu M, Kaminogawa S: Bifidobacterium suppresses IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells. Microbiol Immunol; 2010;54(1):54-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bifidobacterium suppresses IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells.
  • Sixteen heat-killed bifidobacteria isolated from human intestine and a probiotic strain Lactobacillus GG were tested for their ability to influence IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells in vitro.
  • [MeSH-major] Basophils / immunology. Bifidobacterium / physiology. Immunoglobulin E / immunology. Leukemia, Basophilic, Acute / immunology
  • [MeSH-minor] Animals. Basophil Degranulation Test. Cell Line, Tumor. Humans. Intestines / microbiology. Lactobacillus / physiology. Rats. Signal Transduction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20055943.001).
  • [ISSN] 0385-5600
  • [Journal-full-title] Microbiology and immunology
  • [ISO-abbreviation] Microbiol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


8. Li Y, Lee SH, Le QT, Kim MM, Kim SK: Anti-allergic effects of phlorotannins on histamine release via binding inhibition between IgE and Fc epsilonRI. J Agric Food Chem; 2008 Dec 24;56(24):12073-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, anti-allergic activities of phloroglucinol derivatives were assessed on human basophilic leukemia (KU812) and rat basophilic leukemia (RBL-2H3) cell lines using a histamine release assay.

  • MedlinePlus Health Information. consumer health - Allergy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19053379.001).
  • [ISSN] 1520-5118
  • [Journal-full-title] Journal of agricultural and food chemistry
  • [ISO-abbreviation] J. Agric. Food Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Plant Extracts; 0 / Receptors, IgE; 37341-29-0 / Immunoglobulin E; DHD7FFG6YS / Phloroglucinol
  •  go-up   go-down


9. Quan W, Lee HJ, Kim CY, Noh CW, Um BH, Oak MH, Kim KM: Anti-allergic prenylated flavonoids from the roots of Sophora flavescens. Planta Med; 2008 Feb;74(2):168-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Animals. Cell Line, Tumor. Leukemia, Basophilic, Acute. Rats. beta-N-Acetylhexosaminidases / antagonists & inhibitors. beta-N-Acetylhexosaminidases / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18219599.001).
  • [ISSN] 0032-0943
  • [Journal-full-title] Planta medica
  • [ISO-abbreviation] Planta Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Flavonoids; EC 3.2.1.52 / beta-N-Acetylhexosaminidases
  •  go-up   go-down


10. Lebduska P, Korb J, Tůmová M, Heneberg P, Dráber P: Topography of signaling molecules as detected by electron microscopy on plasma membrane sheets isolated from non-adherent mast cells. J Immunol Methods; 2007 Dec 1;328(1-2):139-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The data were compared with those obtained from widely used but tumor-derived rat basophilic leukemia (RBL) cells.

  • MedlinePlus Health Information. consumer health - Laboratory Tests.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17900607.001).
  • [ISSN] 0022-1759
  • [Journal-full-title] Journal of immunological methods
  • [ISO-abbreviation] J. Immunol. Methods
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / Receptors, IgE
  •  go-up   go-down


11. Rashid A, Iodice MW, Carroll KM, Housden JE, Hunter M, Sabban S, Artymiuk PJ, Helm BA: Assessing the role of Asp 194 in the transmembrane domains of the α-chain of the high-affinity receptor complex for immunoglobulin E in signal transduction. Mol Immunol; 2010 Nov-Dec;48(1-3):128-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rat basophilic leukemia cells (RBL-2H3) transfected with the human IgE binding subunit (FcɛRIα) incorporating polar substitutions like asparagine (D194N) or threonine (D194T) resulted in the formation of a functional rat/human chimeric receptor complex.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-ASPARTIC ACID .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • [CommentIn] Mol Immunol. 2011 Apr;48(8):979-80 [21216468.001]
  • (PMID = 20947168.001).
  • [ISSN] 1872-9142
  • [Journal-full-title] Molecular immunology
  • [ISO-abbreviation] Mol. Immunol.
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Receptors, IgE; 30KYC7MIAI / Aspartic Acid
  •  go-up   go-down


12. Yasui Y, Nakamura M, Onda T, Uehara T, Murata S, Matsui N, Fukuishi N, Akagi R, Suematsu M, Akagi M: Heme oxygenase-1 inhibits cytokine production by activated mast cells. Biochem Biophys Res Commun; 2007 Mar 9;354(2):485-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We examined whether rat HO-1 cDNA transfected rat basophilic leukemia (RBL)-2H3 cells have altered cytokine production in response to stimulation with anti-ovalbumin (OA) serum/OA compared to Mock transfected RBL-2H3 cells.


13. Fujimura Y, Yamada K, Tachibana H: A lipid raft-associated 67kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression. Biochem Biophys Res Commun; 2005 Oct 21;336(2):674-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that the 67LR is highly associated with lipid rafts on human basophilic KU812 cells.
  • [MeSH-major] Catechin / analogs & derivatives. Leukemia, Basophilic, Acute / metabolism. Membrane Microdomains / metabolism. Receptors, IgG / metabolism. Receptors, Laminin / metabolism

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16140266.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / FCGR1A protein, human; 0 / Receptors, IgG; 0 / Receptors, Laminin; 8R1V1STN48 / Catechin; BQM438CTEL / epigallocatechin gallate
  •  go-up   go-down


14. Kaito K, Otsubo H, Dobashi N, Usui N, Kobayashi M: CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations. Int J Hematol; 2005 Jan;81(1):29-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations.
  • We report a patient with a variant form of CD2+ acute promyelocytic leukemia (APL) who had double translocations (15;17) in a single leukemic cell.
  • The bone marrow showed marked hyperplasia with large leukemic cells that had bizarre nuclear configuration and basophilic, hypogranular cytoplasm.
  • Fluorescence in situ hybridization assay revealed 2 promyelocytic leukemia and retinoic acid receptor alpha (PML/RARA) fusion signals, and reverse transcription-polymerase chain reaction assay revealed short-form PML/RARA fusion transcript.
  • Tetraploidy in APL is a very rare abnormality.
  • Double translocations were an additional abnormality in this case, and this patient's karyotype might have had some influence on morphological characteristics, expression of CD2, and poor clinical outcome.
  • [MeSH-major] Antigens, CD2 / genetics. Chromosomes, Human, Pair 15. Chromosomes, Human, Pair 17. Leukemia, Promyelocytic, Acute / genetics. Translocation, Genetic

  • Genetic Alliance. consumer health - Acute Promyelocytic Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 1990 Dec 1;172(6):1571-5 [2175343.001]
  • [Cites] Cancer Genet Cytogenet. 1996 Feb;86(2):107-15 [8603334.001]
  • [Cites] Am J Hematol. 2001 May;67(1):34-41 [11279655.001]
  • [Cites] Cancer Genet Cytogenet. 2003 Sep;145(2):169-71 [12935930.001]
  • [Cites] Cancer Res. 2002 Aug 15;62(16):4730-5 [12183432.001]
  • [Cites] Lancet. 1977 Mar 5;1(8010):549-50 [65649.001]
  • [Cites] Cytometry B Clin Cytom. 2004 May;59(1):1-9 [15108165.001]
  • [Cites] Cancer Genet Cytogenet. 2003 Aug;145(1):49-53 [12885462.001]
  • [Cites] Br J Haematol. 2000 Dec;111(3):801-6 [11122141.001]
  • [Cites] Am J Clin Pathol. 2004 Mar;121(3):402-7 [15023045.001]
  • [Cites] Int J Hematol. 2004 May;79(4):405-6 [15218975.001]
  • [Cites] Nature. 1990 Oct 11;347(6293):558-61 [2170850.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Mar;149(2):131-6 [15036889.001]
  • (PMID = 15717685.001).
  • [ISSN] 0925-5710
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antigens, CD2
  •  go-up   go-down


15. Sebastian K, Borowski A, Kuepper M, Friedrich K: Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma. Cell Commun Signal; 2008;6:5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DCs activated by epithelium-derived TSLP can promote naïve CD4+ T cells to adopt a Th2 phenotype, which in turn recruite eosinophilic and basophilic granulocytes as well as mast cells into the airway mucosa.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Allergy Clin Immunol. 2008 May;121(5):1289-90 [18374404.001]
  • [Cites] Mol Cell Biol. 2004 Mar;24(6):2584-92 [14993294.001]
  • [Cites] J Immunol. 2008 Feb 15;180(4):2140-8 [18250420.001]
  • [Cites] J Clin Invest. 2007 Dec;117(12):3868-78 [18060034.001]
  • [Cites] Nan Fang Yi Ke Da Xue Xue Bao. 2007 Oct;27(10):1581-3 [17959543.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1837-47 [17635955.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L375-82 [17513456.001]
  • [Cites] J Immunol. 2007 Jul 15;179(2):1080-7 [17617600.001]
  • [Cites] Trends Immunol. 2007 Jun;28(6):248-51 [17466594.001]
  • [Cites] J Allergy Clin Immunol. 2006 Jun;117(6):1277-84 [16750987.001]
  • [Cites] J Exp Med. 2006 Feb 20;203(2):269-73 [16432252.001]
  • [Cites] J Exp Med. 2005 Nov 7;202(9):1213-23 [16275760.001]
  • [Cites] Nat Immunol. 2005 Oct;6(10):1047-53 [16142237.001]
  • [Cites] J Exp Med. 2005 Sep 19;202(6):829-39 [16172260.001]
  • [Cites] Trends Immunol. 2005 Sep;26(9):462-8 [16027039.001]
  • [Cites] J Exp Med. 2003 Apr 21;197(8):1059-63 [12707303.001]
  • [Cites] Eur J Immunol. 2003 Apr;33(4):861-9 [12672051.001]
  • [Cites] Nat Rev Immunol. 2002 Dec;2(12):933-44 [12461566.001]
  • [Cites] J Allergy Clin Immunol. 2002 Sep;110(3):460-8 [12209095.001]
  • [Cites] Nat Immunol. 2002 Jul;3(7):673-80 [12055625.001]
  • [Cites] J Immunol. 2002 Apr 1;168(7):3288-94 [11907084.001]
  • [Cites] Cytogenet Cell Genet. 2001;93(1-2):23-5 [11474172.001]
  • [Cites] Leukemia. 2001 Aug;15(8):1286-92 [11480573.001]
  • [Cites] Nat Immunol. 2001 Aug;2(8):725-31 [11477409.001]
  • [Cites] J Clin Pathol. 2001 Aug;54(8):577-89 [11477111.001]
  • [Cites] J Immunol. 2001 Jul 1;167(1):336-43 [11418668.001]
  • [Cites] Clin Exp Allergy. 2001 May;31(5):667-9 [11422123.001]
  • [Cites] Nat Immunol. 2000 Jul;1(1):59-64 [10881176.001]
  • [Cites] J Exp Med. 2001 Feb 5;193(3):387-92 [11157058.001]
  • [Cites] J Allergy Clin Immunol. 2000 Nov;106(5):829-31 [11080702.001]
  • [Cites] Am J Respir Cell Mol Biol. 1999 Nov;21(5):586-96 [10536118.001]
  • [Cites] J Exp Med. 2000 Sep 4;192(5):659-70 [10974032.001]
  • [Cites] Biochem Biophys Res Commun. 2000 May 27;272(1):224-9 [10872831.001]
  • [Cites] Blood. 2000 Apr 1;95(7):2204-10 [10733486.001]
  • [Cites] J Exp Med. 2000 Jan 17;191(2):375-80 [10637281.001]
  • [Cites] J Immunol. 1999 Dec 15;163(12):6876-83 [10586089.001]
  • [Cites] J Immunol. 1999 Dec 1;163(11):5971-7 [10570284.001]
  • [Cites] Annu Rev Immunol. 2007;25:193-219 [17129180.001]
  • [Cites] J Exp Med. 2007 Feb 19;204(2):253-8 [17242164.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):914-9 [17213320.001]
  • [Cites] Clin Exp Allergy. 2006 Nov;36(11):1357-66 [17083345.001]
  • [Cites] Respir Res. 2006;7:125 [17034639.001]
  • [Cites] J Immunol. 2006 Sep 15;177(6):4064-71 [16951370.001]
  • [Cites] Curr Allergy Asthma Rep. 2006 Sep;6(5):372-6 [16899198.001]
  • [Cites] Immunity. 2006 Jun;24(6):827-38 [16782037.001]
  • [Cites] Nat Immunol. 2006 Jul;7(7):709-14 [16785889.001]
  • [Cites] Mol Cell. 2006 Jun 9;22(5):561-9 [16762830.001]
  • [Cites] J Immunol. 2005 Jun 15;174(12):8183-90 [15944327.001]
  • [Cites] Blood. 2005 Jun 15;105(12):4749-51 [15741223.001]
  • [Cites] J Immunol. 1999 Jan 15;162(2):677-83 [9916685.001]
  • [Cites] Blood. 1998 Nov 1;92(9):3338-45 [9787171.001]
  • [Cites] Immunity. 1998 Mar;8(3):275-83 [9529145.001]
  • [Cites] Annu Rev Immunol. 1997;15:297-322 [9143690.001]
  • [Cites] Hum Mol Genet. 1997 Apr;6(4):551-4 [9097957.001]
  • [Cites] Nature. 1996 Oct 31;383(6603):787-93 [8893001.001]
  • [Cites] J Allergy Clin Immunol. 1996 Jun;97(6):1288-96 [8648025.001]
  • [Cites] Lancet. 1995 Dec 9;346(8989):1559 [7491066.001]
  • [Cites] Cell. 1988 Apr 22;53(2):211-7 [3129195.001]
  • [Cites] Annu Rev Immunol. 1989;7:145-73 [2523712.001]
  • [Cites] Cancer Res. 2004 Oct 15;64(20):7248-55 [15492243.001]
  • [Cites] J Immunol. 2004 Aug 15;173(4):2771-9 [15294996.001]
  • [Cites] Nat Rev Immunol. 2004 Jul;4(7):499-511 [15229469.001]
  • [Cites] Clin Exp Allergy. 2008 Apr;38(4):619-28 [18266877.001]
  • (PMID = 18724870.001).
  • [ISSN] 1478-811X
  • [Journal-full-title] Cell communication and signaling : CCS
  • [ISO-abbreviation] Cell Commun. Signal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2531181
  •  go-up   go-down


16. Sagi-Eisenberg R: The mast cell: where endocytosis and regulated exocytosis meet. Immunol Rev; 2007 Jun;217:292-303
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Studying the function of Syt II-knocked down rat basophilic leukemia cells has shown a dual function of this homologue.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17498067.001).
  • [ISSN] 0105-2896
  • [Journal-full-title] Immunological reviews
  • [ISO-abbreviation] Immunol. Rev.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Neuronal Calcium-Sensor Proteins; 0 / Neuropeptides; 0 / Receptors, IgE; 0 / frequenin calcium sensor proteins; 134193-27-4 / Synaptotagmins; EC 2.7.11.13 / Protein Kinase C-alpha; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases
  • [Number-of-references] 138
  •  go-up   go-down


17. Dearman RJ, Skinner RA, Deakin N, Shaw D, Kimber I: Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay. Toxicology; 2005 Jan 15;206(2):195-205
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay.
  • We have examined the utility of the rat basophilic leukemia (RBL) cell line for the measurement of murine IgE responses.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15588913.001).
  • [ISSN] 0300-483X
  • [Journal-full-title] Toxicology
  • [ISO-abbreviation] Toxicology
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Allergens; 0 / Antibodies, Monoclonal; 0 / Dinitrobenzenes; 0 / Serum Albumin; 37341-29-0 / Immunoglobulin E; 9006-59-1 / Ovalbumin
  •  go-up   go-down


18. Shaik GM, Dráberová L, Heneberg P, Dráber P: Vacuolin-1-modulated exocytosis and cell resealing in mast cells. Cell Signal; 2009 Aug;21(8):1337-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that in rat basophilic leukemia (RBL-2H3) cells activated by the high-affinity IgE receptor (FcepsilonRI) triggering vacuolin-1 enhanced exocytosis.

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19376224.001).
  • [ISSN] 1873-3913
  • [Journal-full-title] Cellular signalling
  • [ISO-abbreviation] Cell. Signal.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Heterocyclic Compounds with 4 or More Rings; 0 / Receptors, IgE; 0 / vacuolin-1; SY7Q814VUP / Calcium
  •  go-up   go-down


19. Hashimoto Y, Arai I, Tanaka M, Nakaike S: Prostaglandin D2 inhibits IgE-mediated scratching by suppressing histamine release from mast cells. J Pharmacol Sci; 2005 May;98(1):90-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Effects of prostaglandin (PG) D(2), PGE(2), and PGI(2) on itch-associated scratching responses of mice and histamine release from the rat basophilic leukemia cell line RBL-2H3 were examined.

  • MedlinePlus Health Information. consumer health - Itching.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15879676.001).
  • [ISSN] 1347-8613
  • [Journal-full-title] Journal of pharmacological sciences
  • [ISO-abbreviation] J. Pharmacol. Sci.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 37341-29-0 / Immunoglobulin E; RXY07S6CZ2 / Prostaglandin D2
  •  go-up   go-down


20. Heneberg P, Dráberová L, Bambousková M, Pompach P, Dráber P: Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts. J Biol Chem; 2010 Apr 23;285(17):12787-802
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found that exposure of rat basophilic leukemia cells or mouse bone marrow-derived mast cells to PTP inhibitors, H(2)O(2) or pervanadate, induced phosphorylation of the Fc epsilonRI subunits, similarly as Fc epsilonRI triggering.

  • Hazardous Substances Data Bank. HYDROGEN PEROXIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol. 2005 Oct 1;175(7):4543-54 [16177098.001]
  • [Cites] Nat Immunol. 2005 Nov;6(11):1168-76 [16200067.001]
  • [Cites] Nat Rev Immunol. 2006 Mar;6(3):218-30 [16470226.001]
  • [Cites] Mol Pharmacol. 2006 Apr;69(4):1347-55 [16391241.001]
  • [Cites] Physiology (Bethesda). 2006 Dec;21:430-9 [17119156.001]
  • [Cites] Annu Rev Immunol. 2007;25:473-523 [17291189.001]
  • [Cites] J Lipid Res. 2007 Jun;48(6):1325-35 [17387221.001]
  • [Cites] Free Radic Biol Med. 2007 Jul 1;43(1):100-10 [17561098.001]
  • [Cites] Cell Signal. 2007 Nov;19(11):2400-12 [17716862.001]
  • [Cites] J Immunol. 2007 Nov 15;179(10):7059-71 [17982097.001]
  • [Cites] J Cell Biol. 2000 May 29;149(5):1131-42 [10831616.001]
  • [Cites] FEBS Lett. 2000 Jun 16;475(2):121-6 [10858501.001]
  • [Cites] J Biol Chem. 2000 Nov 10;275(45):34976-82 [10956655.001]
  • [Cites] J Struct Biol. 2000 Dec;132(3):201-10 [11243889.001]
  • [Cites] J Cell Biol. 2001 Jan 22;152(2):325-34 [11266449.001]
  • [Cites] Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9 [11413487.001]
  • [Cites] J Cell Biol. 2001 Aug 6;154(3):645-58 [11489921.001]
  • [Cites] Mol Cell Biol. 2001 Nov;21(21):7117-36 [11585896.001]
  • [Cites] Mol Cell Biol. 2001 Dec;21(24):8318-28 [11713268.001]
  • [Cites] Mol Cell. 2002 Feb;9(2):387-99 [11864611.001]
  • [Cites] Int Arch Allergy Immunol. 2002 Aug;128(4):253-63 [12218363.001]
  • [Cites] Mol Immunol. 2002 Sep;38(16-18):1259-68 [12217393.001]
  • [Cites] J Immunol. 2002 Nov 15;169(10):5866-73 [12421969.001]
  • [Cites] Nat Immunol. 2002 Dec;3(12):1129-34 [12447370.001]
  • [Cites] J Immunol. 2003 Oct 1;171(7):3585-93 [14500655.001]
  • [Cites] Cell. 2003 Nov 14;115(4):377-88 [14622593.001]
  • [Cites] J Immunol. 2003 Dec 1;171(11):6119-27 [14634127.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1886-91 [14762163.001]
  • [Cites] Eur J Immunol. 2004 Jun;34(6):1627-36 [15162432.001]
  • [Cites] Eur J Immunol. 2004 Aug;34(8):2209-19 [15259018.001]
  • [Cites] J Exp Med. 2004 Oct 18;200(8):1001-13 [15477348.001]
  • [Cites] J Immunol Methods. 2007 Dec 1;328(1-2):139-51 [17900607.001]
  • [Cites] ACS Chem Biol. 2007 Oct 19;2(10):674-84 [18041817.001]
  • [Cites] FEBS J. 2008 Jan;275(1):69-88 [18067579.001]
  • [Cites] Annu Rev Immunol. 2008;26:29-55 [18303998.001]
  • [Cites] J Biol Chem. 2008 Sep 12;283(37):25544-56 [18617527.001]
  • [Cites] J Immunol. 2008 Oct 15;181(8):5414-24 [18832698.001]
  • [Cites] Cell. 2009 Jan 23;136(2):352-63 [19167335.001]
  • [Cites] Immunol Rev. 2009 Mar;228(1):149-69 [19290926.001]
  • [Cites] EMBO Rep. 2004 Aug;5(8):812-7 [15247926.001]
  • [Cites] J Immunol. 2000 Feb 1;164(3):1521-8 [10640770.001]
  • [Cites] Exp Cell Res. 1977 Feb;104(2):255-62 [65285.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Sep;76(9):4498-502 [291981.001]
  • [Cites] J Immunol. 1980 Jun;124(6):2728-37 [7373045.001]
  • [Cites] Eur J Immunol. 1981 Apr;11(4):317-23 [6166481.001]
  • [Cites] Eur J Immunol. 1981 Jun;11(6):527-9 [6790293.001]
  • [Cites] J Histochem Cytochem. 1988 Sep;36(9):1197-202 [3403970.001]
  • [Cites] Mol Immunol. 1988 Jul;25(7):647-61 [2971137.001]
  • [Cites] J Biol Chem. 1990 Feb 15;265(5):2896-902 [2154464.001]
  • [Cites] Biochemistry. 1990 Nov 6;29(44):10240-5 [2176864.001]
  • [Cites] Nature. 1992 Jan 2;355(6355):78-80 [1370575.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10306-10 [1279675.001]
  • [Cites] Biochem J. 1994 Sep 15;302 ( Pt 3):867-74 [7524478.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11246-50 [7526393.001]
  • [Cites] J Biol Chem. 1995 Sep 15;270(37):21902-6 [7545170.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9201-5 [7568101.001]
  • [Cites] Immunology. 1996 Jan;87(1):141-8 [8666426.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7865-70 [8755568.001]
  • [Cites] J Biol Chem. 1997 Jan 10;272(2):843-51 [8995372.001]
  • [Cites] J Biol Chem. 1997 Feb 14;272(7):4276-80 [9020144.001]
  • [Cites] Eur J Immunol. 1997 Jan;27(1):321-8 [9022035.001]
  • [Cites] J Immunol. 1997 Nov 1;159(9):4426-34 [9379041.001]
  • [Cites] J Cell Biol. 1997 Dec 15;139(6):1447-54 [9396750.001]
  • [Cites] Cell. 1998 Jan 9;92(1):83-92 [9489702.001]
  • [Cites] J Mol Biol. 1998 Feb 13;276(1):1-6 [9514733.001]
  • [Cites] J Biol Chem. 1998 Apr 17;273(16):10036-45 [9545350.001]
  • [Cites] Structure. 1998 Mar 15;6(3):249-54 [9551546.001]
  • [Cites] Biochemistry. 1998 Apr 21;37(16):5633-42 [9548949.001]
  • [Cites] J Biol Chem. 1999 Jan 15;274(3):1753-8 [9880557.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48751-9 [15361524.001]
  • [Cites] Methods. 2005 Jan;35(1):37-43 [15588984.001]
  • [Cites] Arch Biochem Biophys. 2005 Feb 1;434(1):11-5 [15629103.001]
  • [Cites] Cell. 2005 Jun 3;121(5):667-70 [15935753.001]
  • [Cites] Curr Med Chem. 2005;12(16):1859-71 [16101506.001]
  • (PMID = 20157115.001).
  • [ISSN] 1083-351X
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens; 0 / Enzyme Inhibitors; 0 / Oxidants; 0 / Receptors, IgE; 0 / pervanadate; 3WHH0066W5 / Vanadates; BBX060AN9V / Hydrogen Peroxide; EC 2.7.10.2 / lyn protein-tyrosine kinase; EC 2.7.10.2 / src-Family Kinases; EC 3.1.3.48 / Protein Tyrosine Phosphatases
  • [Other-IDs] NLM/ PMC2857068
  •  go-up   go-down


21. Yamashita M: Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells. Eur J Pharmacol; 2007 Feb 5;556(1-3):172-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Peroxisome proliferators Wy-14,643 (30 microM) and fenofibrate (100 microM) significantly inhibited the cysteinyl leukotriene production that was induced by antigen (Ag) treatment after overnight sensitization to Ag specific immunoglobulin E (IgE) in a rat basophilic leukemia (RBL)-2H3 mast cell line.

  • Hazardous Substances Data Bank. Fenofibrate .
  • Hazardous Substances Data Bank. Pirinixic acid .
  • Hazardous Substances Data Bank. CYSTEINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17113579.001).
  • [ISSN] 0014-2999
  • [Journal-full-title] European journal of pharmacology
  • [ISO-abbreviation] Eur. J. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Leukotrienes; 0 / PPAR alpha; 0 / Peroxisome Proliferators; 0 / Pyrimidines; 0 / cysteinyl-leukotriene; 37341-29-0 / Immunoglobulin E; 86C4MRT55A / pirinixic acid; EC 1.13.11.34 / Arachidonate 5-Lipoxygenase; EC 1.3.3.6 / Acyl-CoA Oxidase; EC 3.1.1.- / Phospholipases A; EC 3.2.1.- / Hexosaminidases; K848JZ4886 / Cysteine; U202363UOS / Fenofibrate
  •  go-up   go-down


22. Han X, Jorgensen JL, Brahmandam A, Schlette E, Huh YO, Shi Y, Awagu S, Chen W: Immunophenotypic study of basophils by multiparameter flow cytometry. Arch Pathol Lab Med; 2008 May;132(5):813-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: The immunophenotypic profile of basophils is not yet fully established, and the immunophenotypic changes in chronic myelogenous leukemia are not fully characterized.
  • OBJECTIVE: To establish a comprehensive immunophenotypic spectrum of normal basophils and to assess the range of immunophenotypic aberrations of basophils in chronic myelogenous leukemia.
  • DESIGN: Using 4-color flow cytometry, we compared the immunophenotypic profile of basophils in peripheral blood or bone marrow samples from 20 patients with no evidence of neoplasia to basophils from 15 patients with chronic myelogenous leukemia.
  • Basophils in all chronic myelogenous leukemia patients possessed 1 to 5 immunophenotypic aberrancies.
  • CD34 and CD117 were present in cases with basophilic precursors.
  • CONCLUSIONS: Flow cytometric immunophenotyping can identify immunophenotypic aberrations of basophils in chronic myelogenous leukemia, and discriminate basophils from myeloblasts.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18466030.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Biomarkers
  •  go-up   go-down


23. Chen C, Folch A: A high-performance elastomeric patch clamp chip. Lab Chip; 2006 Oct;6(10):1338-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we demonstrate a replica-molded elastomeric patch clamp chip incorporating nanofabricated constrictions, which delivers high-stability gigaseals, with success rates comparable to those of pipettes, using rat basophilic leukemia (RBL) cells.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17102847.001).
  • [ISSN] 1473-0197
  • [Journal-full-title] Lab on a chip
  • [ISO-abbreviation] Lab Chip
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / RR16302
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ion Channels
  •  go-up   go-down


24. Steinmetz C, Shabaik A, Hasteh F: Systemic mastocytosis associated with small lymphocytic lymphoma: an incidental finding in a patient with invasive gastric adenocarcinoma. Diagn Cytopathol; 2007 Nov;35(11):728-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Diff-Quick touch preparation of the lymph node revealed abundant single cells and loose aggregates of cells with round to oval nuclei and deeply basophilic granules.
  • [MeSH-major] Adenocarcinoma / pathology. Leukemia, Lymphocytic, Chronic, B-Cell / pathology. Mastocytosis, Systemic / pathology. Neoplasms, Multiple Primary / pathology. Stomach Neoplasms / pathology


25. Matsui T, Ito C, Itoigawa M, Okada T, Furukawa H: Anti-inflammatory activity of phenylpropanoids and phytoquinoids from Illicium species in RBL-2H3 cells. Planta Med; 2007 Jun;73(7):662-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two phenylpropanoids, 1-allyl-3,5-dimethoxy-4-(3-methyl-but-2-enyloxy)benzene ( 4) and 4-allyl-2,6-dimethoxy-3-(3-methyl-2-butenyl)phenol ( 6), and two phytoquinoids, 4 R-(-)-illicinone-A ( 7) and 2 S,4 R-(-)-illicinone-B ( 8), isolated from plants of the ILLICIUM species significantly inhibited histamine release from rat basophilic leukemia (RBL-2H3) cells stimulated with A23187.

  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17538871.001).
  • [ISSN] 0032-0943
  • [Journal-full-title] Planta medica
  • [ISO-abbreviation] Planta Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Plant Extracts
  •  go-up   go-down


26. Yamaki K, Yoshino S: Enhancement of FcɛRI-mediated degranulation response in the rat basophilic leukemia cell line RBL2H3 by the fluorosurfactants perfluorooctanoic acid and perfluorooctane sulfonate. Environ Toxicol Pharmacol; 2010 Mar;29(2):183-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Enhancement of FcɛRI-mediated degranulation response in the rat basophilic leukemia cell line RBL2H3 by the fluorosurfactants perfluorooctanoic acid and perfluorooctane sulfonate.
  • The effect of two fluorosurfactants, perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), on degranulation of rat basophilic leukemia RBL2H3 cells was investigated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 21787600.001).
  • [ISSN] 1872-7077
  • [Journal-full-title] Environmental toxicology and pharmacology
  • [ISO-abbreviation] Environ. Toxicol. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


27. Chang KP, Lai CH, Huang SH, Tai HT, Chang LL, Lin SD, Hwang SL, Lai CS: Downregulation of Janus kinase 3 expression by small interfering RNA in rat composite tissue allotransplantation. Transpl Immunol; 2009 May;21(1):27-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The expression vector containing the pre-mRNA expression cassette was transfected into rat basophilic leukemia cell line, RBL-2H3, for RNAi analysis (in vitro).

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19233270.001).
  • [ISSN] 1878-5492
  • [Journal-full-title] Transplant immunology
  • [ISO-abbreviation] Transpl. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Jak3 protein, rat; 0 / RNA, Small Interfering; EC 2.7.10.2 / Janus Kinase 3
  •  go-up   go-down


28. Ueda N, Tsuboi K, Lambert DM: A second N-acylethanolamine hydrolase in mammalian tissues. Neuropharmacology; 2005 Jun;48(8):1079-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The inhibitor was a useful tool to distinguish the acid amidase from FAAH with rat basophilic leukemia (RBL-1) cells that express both the enzymes.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15910884.001).
  • [ISSN] 1873-7064
  • [Journal-full-title] Neuropharmacology
  • [ISO-abbreviation] Neuropharmacology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Arachidonic Acids; 0 / Endocannabinoids; 0 / Ethanolamines; 0 / Organophosphonates; 0 / Palmitic Acids; 0 / methyl arachidonylfluorophosphonate; 57KD15003I / Phenylmethylsulfonyl Fluoride; 6R8T1UDM3V / palmidrol; EC 3.5.- / Amidohydrolases; EC 3.5.1.- / N-acylethanolamine amidohydrolase; EC 3.5.1.- / fatty-acid amide hydrolase; T8ID5YZU6Y / Dithiothreitol
  •  go-up   go-down


29. Frossi B, Rivera J, Hirsch E, Pucillo C: Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol; 2007 Feb 15;178(4):2549-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously demonstrated that hydrogen peroxide (H(2)O(2)) promotes IL-4 and IL-6 mRNA production and potentates FcepsilonRI-induced cytokine release in rat basophilic leukemia RBL-2H3 cells.


30. Chen HJ, Shih CK, Hsu HY, Chiang W: Mast cell-dependent allergic responses are inhibited by ethanolic extract of adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) testa. J Agric Food Chem; 2010 Feb 24;58(4):2596-601
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of this study was to investigate the effects of adlay (Job's tears, Coix lachryma-jobi L. var. ma-yuen Stapf) testa against beta-hexosaminidase release as a marker of degranulation in rat basophilic leukemia (RBL)-2H3 cells.
  • [MeSH-minor] Acetophenones / pharmacology. Animals. Cell Line, Tumor / drug effects. Cell Line, Tumor / immunology. Coumaric Acids / pharmacology. Ethanol. Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors. Extracellular Signal-Regulated MAP Kinases / drug effects. Leukemia, Basophilic, Acute. Phosphorylation / drug effects. Rats. Signal Transduction / drug effects. Signal Transduction / physiology. beta-N-Acetylhexosaminidases / drug effects. beta-N-Acetylhexosaminidases / secretion

  • MedlinePlus Health Information. consumer health - Allergy.
  • Hazardous Substances Data Bank. ETHANOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20102206.001).
  • [ISSN] 1520-5118
  • [Journal-full-title] Journal of agricultural and food chemistry
  • [ISO-abbreviation] J. Agric. Food Chem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acetophenones; 0 / Coumaric Acids; 0 / Plant Extracts; 3K9958V90M / Ethanol; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 3.2.1.52 / beta-N-Acetylhexosaminidases; G1L3HT4CMH / 4-hydroxyacetophenone; IBS9D1EU3J / 4-coumaric acid
  •  go-up   go-down


31. Takahashi Y, Yoneyama S, Yamamoto S, Shibahara T, Kadota K: Acute basophilic leukaemia in a calf. Vet Rec; 2006 May 20;158(20):702-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute basophilic leukaemia in a calf.
  • [MeSH-major] Cattle Diseases / diagnosis. Leukemia, Basophilic, Acute / veterinary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16714438.001).
  • [ISSN] 0042-4900
  • [Journal-full-title] The Veterinary record
  • [ISO-abbreviation] Vet. Rec.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


32. Thors L, Eriksson J, Fowler CJ: Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol; 2007 Nov;152(5):744-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND PURPOSE: Genistein, a tyrosine kinase inhibitor used to block caveolae dependent endocytosis, reduces the cellular uptake of anandamide in RBL2H3 basophilic leukaemia cells.

  • Hazardous Substances Data Bank. TRITIUM, RADIOACTIVE .
  • Hazardous Substances Data Bank. GENISTEIN .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1999 Oct 29;274(44):31119-22 [10531298.001]
  • [Cites] Br J Pharmacol. 2007 Apr;150(7):951-60 [17325653.001]
  • [Cites] Chem Phys Lipids. 2000 Nov;108(1-2):123-34 [11106786.001]
  • [Cites] J Biol Chem. 2001 Mar 9;276(10):6967-73 [11118429.001]
  • [Cites] J Biol Chem. 2002 Apr 19;277(16):13673-81 [11834728.001]
  • [Cites] Biochem J. 2002 Oct 1;367(Pt 1):203-8 [12095417.001]
  • [Cites] FEBS Lett. 2002 Nov 6;531(2):343-7 [12417339.001]
  • [Cites] Nat Med. 2003 Jan;9(1):76-81 [12461523.001]
  • [Cites] J Cell Sci. 2003 Dec 1;116(Pt 23):4707-14 [14600257.001]
  • [Cites] Br J Pharmacol. 2004 Feb;141(3):457-67 [14718261.001]
  • [Cites] Eur J Pharm Sci. 2004 Jun;22(2-3):181-9 [15158903.001]
  • [Cites] Biochemistry. 2004 Jun 29;43(25):8184-90 [15209515.001]
  • [Cites] Eur J Neurosci. 2004 Jul;20(2):459-66 [15233754.001]
  • [Cites] J Biochem Biophys Methods. 2004 Aug 31;60(2):171-7 [15262451.001]
  • [Cites] J Biol Chem. 2004 Oct 1;279(40):41991-7 [15292270.001]
  • [Cites] Biochem J. 1974 Jun;139(3):715-20 [4854723.001]
  • [Cites] J Biol Chem. 1985 Nov 15;260(26):14145-9 [4055775.001]
  • [Cites] J Biol Chem. 1987 Apr 25;262(12):5592-5 [3106339.001]
  • [Cites] Biochem Pharmacol. 1993 Sep 1;46(5):791-6 [8373432.001]
  • [Cites] Nature. 1994 Dec 15;372(6507):686-91 [7990962.001]
  • [Cites] J Biol Chem. 1997 Feb 7;272(6):3315-23 [9013571.001]
  • [Cites] Neurosci Lett. 1998 Oct 2;254(3):137-40 [10214976.001]
  • [Cites] Pharmacol Ther. 2004 Nov;104(2):117-35 [15518883.001]
  • [Cites] Life Sci. 2005 Feb 25;76(15):1747-57 [15698853.001]
  • [Cites] Cell Mol Life Sci. 2005 Feb;62(3):386-95 [15723173.001]
  • [Cites] Chem Phys Lipids. 2005 Apr;134(2):131-9 [15784231.001]
  • [Cites] J Neurosci Res. 2005 Jul 15;81(2):275-83 [15920744.001]
  • [Cites] APMIS. 2005 May;113(5):332-9 [16011659.001]
  • [Cites] Histochem Cell Biol. 2005 Jun;123(6):613-20 [15889267.001]
  • [Cites] J Lipid Res. 2005 Aug;46(8):1652-9 [15930521.001]
  • [Cites] Life Sci. 2005 Aug 19;77(14):1584-604 [15979096.001]
  • [Cites] J Biol Chem. 2006 Apr 7;281(14):9066-75 [16461355.001]
  • [Cites] J Am Chem Soc. 2006 Aug 2;128(30):9699-704 [16866524.001]
  • [Cites] Br J Pharmacol. 2006 Sep;149(1):73-81 [16865094.001]
  • [Cites] Pharmacol Res. 2006 Dec;54(6):481-5 [16997568.001]
  • [Cites] Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23 [16736384.001]
  • [Cites] Cell Mol Life Sci. 2007 Jan;64(2):219-29 [17187172.001]
  • [Cites] J Pharmacol Exp Ther. 2000 Mar;292(3):960-7 [10688610.001]
  • (PMID = 17676056.001).
  • [ISSN] 0007-1188
  • [Journal-full-title] British journal of pharmacology
  • [ISO-abbreviation] Br. J. Pharmacol.
  • [Language] ENG
  • [Grant] United States / NIDA NIH HHS / DA / DA009789-12A17961; United States / NIDA NIH HHS / DA / P01 DA009789; United States / NIDA NIH HHS / DA / P01 DA009789-12A17961
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Arachidonic Acids; 0 / Benzamides; 0 / Carbamates; 0 / Endocannabinoids; 0 / Isoflavones; 0 / Polyunsaturated Alkamides; 0 / Protein Kinase Inhibitors; 0 / cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester; 10028-17-8 / Tritium; 6287WC5J2L / daidzein; 94421-68-8 / anandamide; DH2M523P0H / Genistein; EC 3.5.- / Amidohydrolases; EC 3.5.1.- / fatty-acid amide hydrolase
  • [Other-IDs] NLM/ PMC2190009
  •  go-up   go-down


33. Nigro EA, Brini AT, Soprana E, Ambrosi A, Dombrowicz D, Siccardi AG, Vangelista L: Antitumor IgE adjuvanticity: key role of Fc epsilon RI. J Immunol; 2009 Oct 1;183(7):4530-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / immunology. Adenocarcinoma / pathology. Adenocarcinoma / therapy. Animals. Antigens, Neoplasm / immunology. Cancer Vaccines / administration & dosage. Cancer Vaccines / genetics. Cancer Vaccines / immunology. Cell Line, Tumor. Cross-Linking Reagents / administration & dosage. Cross-Linking Reagents / metabolism. Cross-Linking Reagents / therapeutic use. Female. Gene Knock-In Techniques. Humans. Leukemia, Basophilic, Acute / immunology. Leukemia, Basophilic, Acute / pathology. Leukemia, Basophilic, Acute / therapy. Lymphoma, T-Cell / immunology. Lymphoma, T-Cell / pathology. Lymphoma, T-Cell / therapy. Mammary Neoplasms, Experimental / immunology. Mammary Neoplasms, Experimental / pathology. Mammary Neoplasms, Experimental / therapy. Mice. Mice, Inbred BALB C. Mice, Inbred C57BL. Mice, Knockout. Mice, Transgenic. Rats

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Archivio Istituzionale della Ricerca Unimi. Full text from AIR - Univ. Milan .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19748979.001).
  • [ISSN] 1550-6606
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Antigens, Neoplasm; 0 / Antineoplastic Agents; 0 / Cancer Vaccines; 0 / Cross-Linking Reagents; 0 / Receptors, IgE; 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


34. Urrea Moreno R, Gil J, Rodriguez-Sainz C, Cela E, LaFay V, Oloizia B, Herr AB, Sumegi J, Jordan MB, Risma KA: Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function. Blood; 2009 Jan 8;113(2):338-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a family affected by hemophagocytic lymphohistiocytosis, a severe inflammatory disorder caused by perforin deficiency, we identified 2 amino acid substitutions in the perforin C2 domain: T435M, a previously identified mutant with disputed pathogenicity, and Y438C, a novel substitution.
  • The capacity for cytotoxic function was tested after expression of the variant perforins in rat basophilic leukemia cells and murine cytotoxic T lymphocytes.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 1999 Dec 3;286(5446):1957-9 [10583959.001]
  • [Cites] Cell Microbiol. 2008 Sep;10(9):1765-74 [18564372.001]
  • [Cites] Am J Med Genet A. 2003 Mar 15;117A(3):255-60 [12599189.001]
  • [Cites] Nat Immunol. 2003 May;4(5):399-403 [12719728.001]
  • [Cites] Blood. 2004 Feb 15;103(4):1244-52 [14576041.001]
  • [Cites] J Med Genet. 2004 Feb;41(2):137-44 [14757862.001]
  • [Cites] Blood. 2004 Aug 1;104(3):735-43 [15069016.001]
  • [Cites] Blood. 2004 Sep 15;104(6):1909; author reply 1910 [15342365.001]
  • [Cites] J Exp Med. 2004 Sep 20;200(6):811-6 [15365097.001]
  • [Cites] J Exp Med. 1984 Jul 1;160(1):75-93 [6736872.001]
  • [Cites] J Exp Med. 1984 Sep 1;160(3):695-710 [6332169.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Sep;81(17):5551-5 [6591203.001]
  • [Cites] Cell. 1991 Mar 22;64(6):1175-81 [2004423.001]
  • [Cites] Cell. 1992 Oct 16;71(2):315-22 [1423596.001]
  • [Cites] Eur J Immunol. 1995 Apr;25(4):1071-9 [7737276.001]
  • [Cites] Curr Top Microbiol Immunol. 1995;198:39-58 [7774282.001]
  • [Cites] Protein Sci. 1996 Jan;5(1):162-6 [8771209.001]
  • [Cites] J Pediatr Hematol Oncol. 1996 Nov;18(4):340-5 [8888739.001]
  • [Cites] Protein Sci. 1996 Dec;5(12):2375-90 [8976547.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7287-96 [9405358.001]
  • [Cites] J Biol Chem. 1998 Jun 26;273(26):15879-82 [9632630.001]
  • [Cites] J Biol Chem. 2005 Mar 4;280(9):8426-34 [15576364.001]
  • [Cites] Blood. 2005 Apr 1;105(7):2658-63 [15598808.001]
  • [Cites] Blood. 2005 May 1;105(9):3442-8 [15632205.001]
  • [Cites] Blood. 2005 Jun 1;105(11):4424-8 [15728124.001]
  • [Cites] J Immunol Methods. 2005 Apr;299(1-2):117-27 [15914196.001]
  • [Cites] Haematologica. 2005 May;90(5):697-8 [15921391.001]
  • [Cites] J Clin Invest. 2006 Jan;116(1):182-92 [16374518.001]
  • [Cites] J Pediatr. 2006 Jul;149(1):134-7 [16860143.001]
  • [Cites] Pediatr Blood Cancer. 2007 Feb;48(2):124-31 [16937360.001]
  • [Cites] Am J Hematol. 2007 Jun;82(6):427-32 [17266056.001]
  • [Cites] Int J Immunogenet. 2007 Aug;34(4):231-3 [17627755.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1184-90 [17475905.001]
  • [Cites] J Med Genet. 2008 Jan;45(1):15-21 [17873118.001]
  • [Cites] Br J Haematol. 2002 Jun;117(4):965-72 [12060139.001]
  • (PMID = 18927437.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL091769; United States / PHS HHS / / K12 CHILD HEALTH RESEARCH CAREER DEVELOPMENT AWARD; United States / NHLBI NIH HHS / HL / R01-HL091769
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Lipids; 126465-35-8 / Perforin; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ PMC2615650
  •  go-up   go-down


35. Su Z, Guo X, Barker DS, Shoemaker RL, Marchase RB, Blalock JE: A store-operated nonselective cation channel in human lymphocytes. Cell Mol Neurobiol; 2005 Jun;25(3-4):625-47
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Animals. Biological Transport / drug effects. Biological Transport / immunology. Calcium / metabolism. Cations / metabolism. Enzyme Inhibitors / pharmacology. Humans. Jurkat Cells. Leukemia, Basophilic, Acute. Membrane Potentials / drug effects. Membrane Potentials / immunology. Rats. Sodium / metabolism. TRPM Cation Channels. Thapsigargin / pharmacology. Transfection

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SODIUM .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell. 2002 Jan;9(1):163-73 [11804595.001]
  • [Cites] J Biol Chem. 1998 Jan 2;273(1):133-42 [9417057.001]
  • [Cites] J Biol Chem. 1994 Dec 23;269(51):32055-8 [7798198.001]
  • [Cites] J Biol Chem. 1997 Feb 21;272(8):4753-8 [9030528.001]
  • [Cites] Biochem J. 1996 Mar 1;314 ( Pt 2):679-86 [8670085.001]
  • [Cites] Cell. 1996 May 31;85(5):661-71 [8646775.001]
  • [Cites] J Gen Physiol. 1995 Feb;105(2):209-26 [7760017.001]
  • [Cites] Curr Opin Immunol. 2003 Jun;15(3):299-307 [12787755.001]
  • [Cites] J Biol Chem. 1994 Oct 21;269(42):26239-42 [7929340.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15195-202 [8986787.001]
  • [Cites] J Biol Chem. 1994 May 20;269(20):14359-62 [8182038.001]
  • [Cites] EMBO J. 1998 Apr 1;17 (7):1973-85 [9524120.001]
  • [Cites] Science. 1997 Oct 3;278(5335):114-7 [9311914.001]
  • [Cites] J Gen Physiol. 2002 Aug;120(2):221-35 [12149283.001]
  • [Cites] J Immunol. 1999 Jun 1;162(11):6534-42 [10352269.001]
  • [Cites] Am J Physiol Cell Physiol. 2001 May;280(5):C1284-92 [11287342.001]
  • [Cites] Biochem J. 1993 Apr 15;291 ( Pt 2):447-51 [8484725.001]
  • [Cites] Annu Rev Immunol. 2001;19:497-521 [11244045.001]
  • [Cites] Biophys J. 2004 Feb;86(2):805-14 [14747316.001]
  • [Cites] J Gen Physiol. 2002 May;119(5):487-507 [11981025.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11777-82 [11553786.001]
  • [Cites] J Biol Chem. 2001 Dec 21;276(51):47767-70 [11687570.001]
  • [Cites] J Physiol. 2002 Feb 1;538(Pt 3):717-28 [11826160.001]
  • [Cites] J Leukoc Biol. 1996 Sep;60(3):345-55 [8830791.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Oct 9;239(1):279-83 [9345310.001]
  • [Cites] J Biol Chem. 1998 Apr 24;273(17):10279-87 [9553080.001]
  • [Cites] Nature. 2001 May 31;411(6837):590-5 [11385574.001]
  • [Cites] Trends Pharmacol Sci. 1994 Mar;15(3):77-83 [8184490.001]
  • [Cites] J Biol Chem. 2002 Jun 28;277(26):23150-6 [11960981.001]
  • [Cites] Cell Signal. 2000 May;12 (5):289-96 [10822169.001]
  • [Cites] J Biol Chem. 1995 Jun 16;270(24):14445-51 [7540169.001]
  • [Cites] Biochem Biophys Res Commun. 1993 Jul 15;194(1):287-93 [8333842.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):121-6 [9874782.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6295-9 [8392195.001]
  • [Cites] Nature. 1987 Mar 19-25;326(6110):301-4 [2434867.001]
  • [Cites] J Biol Chem. 1996 Dec 20;271(51):32523-8 [8955076.001]
  • [Cites] EMBO J. 1996 Nov 15;15(22):6166-71 [8947038.001]
  • [Cites] J Physiol. 2002 Mar 1;539(Pt 2):445-58 [11882677.001]
  • [Cites] J Cell Biol. 1997 Sep 22;138(6):1333-41 [9298988.001]
  • [Cites] Cell. 1999 Mar 5;96(5):611-4 [10089876.001]
  • [Cites] J Biol Chem. 1999 Dec 24;274(52):36957-62 [10601250.001]
  • [Cites] J Membr Biol. 1999 Mar 1;168(1):9-17 [10051685.001]
  • [Cites] J Biol Chem. 1989 Jan 15;264(2):1068-76 [2562953.001]
  • [Cites] Cell. 1995 Jan 27;80(2):259-68 [7834745.001]
  • [Cites] Cell Calcium. 1996 Jul;20(1):31-41 [8864569.001]
  • [Cites] Biochem Soc Trans. 2003 Oct;31(Pt 5):925-9 [14505450.001]
  • [Cites] Nature. 1999 Jan 21;397(6716):259-63 [9930701.001]
  • [Cites] Science. 2001 Feb 9;291(5506):1043-7 [11161216.001]
  • [Cites] J Biol Chem. 2002 Dec 6;277(49):47175-83 [12361955.001]
  • [Cites] J Immunol. 1994 Jun 1;152(11):5226-40 [8189045.001]
  • [Cites] Am J Physiol Cell Physiol. 2003 Feb;284(2):C497-505 [12388110.001]
  • [Cites] Cell Calcium. 1996 Jul;20(1):11-9 [8864567.001]
  • [Cites] Cell Regul. 1989 Nov;1(1):99-112 [2519622.001]
  • [Cites] J Biol Chem. 1985 Mar 25;260(6):3440-50 [3838314.001]
  • [Cites] Prog Neurobiol. 2002 Mar;66(4):243-64 [11960680.001]
  • [Cites] J Biol Chem. 1989 Nov 15;264(32):19458-67 [2478559.001]
  • [Cites] Cell. 1997 Jun 13;89(6):973-80 [9200615.001]
  • [Cites] J Biol Chem. 1997 Nov 21;272(47):29672-80 [9368034.001]
  • [Cites] Am J Physiol. 1992 Dec;263(6 Pt 1):C1119-40 [1282295.001]
  • [Cites] J Biol Chem. 1990 Nov 15;265(32):19543-50 [2174043.001]
  • [Cites] J Biol Chem. 1999 Jul 30;274(31):21953-62 [10419518.001]
  • [Cites] Cell. 1994 Jan 28;76(2):263-74 [8293463.001]
  • [Cites] Nature. 1993 Aug 26;364(6440):809-14 [8355806.001]
  • [Cites] Sci STKE. 2001 Jul 10;2001(90):re1 [11752662.001]
  • [Cites] J Physiol. 2004 May 15;557(Pt 1):121-32 [15020691.001]
  • [Cites] J Biol Chem. 1997 Nov 28;272(48):30567-76 [9374553.001]
  • [Cites] J Biol Chem. 2004 Mar 26;279(13):12427-37 [14718545.001]
  • [Cites] FEBS Lett. 1998 Feb 6;422(3):333-8 [9498810.001]
  • [Cites] J Biol Chem. 1995 Jan 6;270(1):29-32 [7814389.001]
  • [Cites] Cell. 1993 Oct 22;75(2):199-201 [8402906.001]
  • [Cites] Arch Biochem Biophys. 2000 Feb 15;374(2):213-21 [10666300.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Jan;278(1):C163-73 [10644524.001]
  • [Cites] Biophys J. 1996 Aug;71(2):787-94 [8842217.001]
  • [Cites] Neuron. 1996 Jun;16(6):1069-72 [8663982.001]
  • [Cites] J Biol Chem. 1998 Jun 12;273(24):14925-32 [9614097.001]
  • [Cites] Nature. 2001 May 31;411(6837):595-9 [11385575.001]
  • [Cites] Nature. 1993 Jan 28;361(6410):315-25 [8381210.001]
  • [Cites] Neuron. 1996 Jun;16(6):1189-96 [8663995.001]
  • [Cites] Exp Cell Res. 1995 Jan;216(1):222-31 [7813624.001]
  • [Cites] Physiol Rev. 1997 Oct;77(4):901-30 [9354808.001]
  • [Cites] Science. 2001 Aug 17;293(5533):1327-30 [11509734.001]
  • [Cites] J Physiol. 1993 Jun;465:359-86 [8229840.001]
  • [Cites] Cell Calcium. 1998 Jan;23 (1):53-63 [9570010.001]
  • [Cites] Nature. 2001 Apr 5;410(6829):705-9 [11287959.001]
  • [Cites] Biochem J. 1993 Jul 15;293 ( Pt 2):395-8 [8343120.001]
  • [Cites] J Clin Invest. 1994 Nov;94(5):2002-8 [7962546.001]
  • [Cites] News Physiol Sci. 1998 Oct;13:211-217 [11390792.001]
  • [Cites] EMBO J. 1998 Aug 3;17(15):4274-82 [9687496.001]
  • [Cites] Bioessays. 1999 Jan;21(1):38-46 [10070252.001]
  • (PMID = 16075382.001).
  • [ISSN] 0272-4340
  • [Journal-full-title] Cellular and molecular neurobiology
  • [ISO-abbreviation] Cell. Mol. Neurobiol.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI37670; United States / NIDDK NIH HHS / DK / DK55647; United States / NHLBI NIH HHS / HL / HL68806
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cations; 0 / Enzyme Inhibitors; 0 / Ion Channels; 0 / Membrane Proteins; 0 / TRPM Cation Channels; 0 / TRPM2 protein, human; 67526-95-8 / Thapsigargin; 9NEZ333N27 / Sodium; SY7Q814VUP / Calcium
  •  go-up   go-down


36. Chen R, Chen JY, Zhou LW: Metabolic patterns (NAD(P)H) in rat basophilic leukemia (RBL-2H3) cells and human hepatocellular carcinoma (Hep G2) cells with autofluorescence imaging. Ultrastruct Pathol; 2008 Sep-Oct;32(5):193-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolic patterns (NAD(P)H) in rat basophilic leukemia (RBL-2H3) cells and human hepatocellular carcinoma (Hep G2) cells with autofluorescence imaging.
  • In this work, the dynamic NAD(P)H distributions in rat basophilic leukemia (RBL-2H3) and human hepatocellular carcinoma (Hep G2) cells were studied by imaging the autofluorescence of cellular NAD(P)H with a sensitive CCD detector in a confocal microscope.
  • [MeSH-major] Carcinoma, Hepatocellular / metabolism. Leukemia, Basophilic, Acute / metabolism. Liver Neoplasms / metabolism. Microscopy, Confocal. NADP / metabolism

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18958792.001).
  • [ISSN] 1521-0758
  • [Journal-full-title] Ultrastructural pathology
  • [ISO-abbreviation] Ultrastruct Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 53-59-8 / NADP
  •  go-up   go-down


37. Kim Y, Lee YS, Hahn JH, Choe J, Kwon HJ, Ro JY, Jeoung D: Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect. Mol Immunol; 2008 May;45(9):2537-47
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • HA exerted negative effects on beta-hexoaminidase secretion and histamine release in antigen-stimulated rat basophilic leukemia (RBL2H3) cells.


38. Zhang Y, Mi L, Xiong R, Wang PN, Chen JY, Yang W, Wang C, Peng Q: Subcellular Localization of Thiol-Capped CdTe Quantum Dots in Living Cells. Nanoscale Res Lett; 2009;4(7):606-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These unfunctionalized QDs were well internalized into human hepatocellular carcinoma and rat basophilic leukemia cells in vitro.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20596411.001).
  • [ISSN] 1931-7573
  • [Journal-full-title] Nanoscale research letters
  • [ISO-abbreviation] Nanoscale Res Lett
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Risma KA, Frayer RW, Filipovich AH, Sumegi J: Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest; 2006 Jan;116(1):182-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have shown, for the first time to our knowledge, that recombinant human perforin is expressed, processed appropriately, and functional in rat basophilic leukemia (RBL) cells following retroviral transduction.

  • Genetic Alliance. consumer health - Hemophagocytic Lymphohistiocytosis (HLH).
  • COS Scholar Universe. author profiles.
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 1998 Jun 1;187(11):1903-20 [9607930.001]
  • [Cites] Annu Rev Immunol. 2002;20:323-70 [11861606.001]
  • [Cites] N Engl J Med. 2005 Jan 20;352(3):306-7; author reply 306-7 [15659737.001]
  • [Cites] J Biol Chem. 2005 Mar 4;280(9):8426-34 [15576364.001]
  • [Cites] Blood. 2005 Apr 1;105(7):2658-63 [15598808.001]
  • [Cites] Blood. 2005 May 1;105(9):3442-8 [15632205.001]
  • [Cites] Eur J Pediatr. 2005 May;164(5):315-9 [15731905.001]
  • [Cites] Blood. 2005 Jun 1;105(11):4424-8 [15728124.001]
  • [Cites] Haematologica. 2005 May;90(5):697-8 [15921391.001]
  • [Cites] Blood. 2005 Jun 15;105(12):4700-6 [15755897.001]
  • [Cites] Br J Haematol. 2002 Jun;117(4):965-72 [12060139.001]
  • [Cites] Blood. 2002 Sep 15;100(6):2266-7 [12229880.001]
  • [Cites] Blood. 2002 Oct 1;100(7):2367-73 [12239144.001]
  • [Cites] Br J Haematol. 2003 May;121(3):503-10 [12716377.001]
  • [Cites] J Immunol Methods. 2003 May 1;276(1-2):59-68 [12738359.001]
  • [Cites] Blood. 2004 Feb 15;103(4):1244-52 [14576041.001]
  • [Cites] J Med Genet. 2004 Feb;41(2):137-44 [14757862.001]
  • [Cites] Blood. 2004 Jun 15;103(12):4610-2 [14739222.001]
  • [Cites] Blood. 2004 Aug 1;104(3):735-43 [15069016.001]
  • [Cites] Blood. 2004 Sep 15;104(6):1909; author reply 1910 [15342365.001]
  • [Cites] J Exp Med. 2004 Sep 20;200(6):811-6 [15365097.001]
  • [Cites] J Leukoc Biol. 2004 Oct;76(4):876-85 [15240756.001]
  • [Cites] Eur J Immunol. 1981 Apr;11(4):317-23 [6166481.001]
  • [Cites] J Cell Biol. 1983 Jul;97(1):52-61 [6408102.001]
  • [Cites] J Exp Med. 1984 Jul 1;160(1):75-93 [6736872.001]
  • [Cites] J Exp Med. 1984 Sep 1;160(3):695-710 [6332169.001]
  • [Cites] Nature. 1988 Sep 29;335(6189):448-51 [3419519.001]
  • [Cites] Int Immunol. 1990;2(7):677-84 [2278998.001]
  • [Cites] Cell. 1991 Mar 22;64(6):1175-81 [2004423.001]
  • [Cites] Cell. 1992 Oct 16;71(2):315-22 [1423596.001]
  • [Cites] J Leukoc Biol. 1993 Dec;54(6):528-33 [8245705.001]
  • [Cites] Nature. 1994 May 5;369(6475):31-7 [8164737.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10854-8 [7526382.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7287-96 [9405358.001]
  • [Cites] Blood. 2005 Aug 1;106(3):932-7 [15741215.001]
  • [Cites] J Med Genet. 2001 Sep;38(9):643-6 [11565555.001]
  • [Cites] Science. 1999 Dec 3;286(5446):1957-9 [10583959.001]
  • [Cites] Blood. 2000 Sep 1;96(5):1646-54 [10961859.001]
  • [Cites] Am J Hum Genet. 2001 Mar;68(3):590-7 [11179007.001]
  • [Cites] Blood. 2002 Jan 1;99(1):61-6 [11756153.001]
  • [Cites] Br J Haematol. 2002 Feb;116(2):346-9 [11841437.001]
  • [Cites] J Virol. 1999 Mar;73(3):2527-36 [9971838.001]
  • (PMID = 16374518.001).
  • [ISSN] 0021-9738
  • [Journal-full-title] The Journal of clinical investigation
  • [ISO-abbreviation] J. Clin. Invest.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / T32 HD043005; United States / NICHD NIH HHS / HD / T32 HD43005-02B
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Glycoproteins; 0 / Pore Forming Cytotoxic Proteins; 126465-35-8 / Perforin
  • [Other-IDs] NLM/ PMC1319223
  •  go-up   go-down


40. [Picture in clinical hematology. Acute basophilic leukemia]. Rinsho Ketsueki; 2007 Jan;48(1):1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Picture in clinical hematology. Acute basophilic leukemia].
  • [MeSH-major] Leukemia, Basophilic, Acute / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17313070.001).
  • [ISSN] 0485-1439
  • [Journal-full-title] [Rinshō ketsueki] The Japanese journal of clinical hematology
  • [ISO-abbreviation] Rinsho Ketsueki
  • [Language] jpn
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


41. Grodzki AC, Moon KD, Berenstein EH, Siraganian RP: FcepsilonRI-induced activation by low antigen concentrations results in nuclear signals in the absence of degranulation. Mol Immunol; 2009 Aug;46(13):2539-47
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FcvarepsilonRI-induced mast cell activation was analyzed at a single cell basis using a rat basophilic leukemia (RBL-2H3) cell line transfected with a reporter plasmid containing three tandem NFAT (nuclear factor of activated T cells) binding sites fused to enhanced green fluorescent protein (GFP).

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Immunity. 2000 May;12(5):525-35 [10843385.001]
  • [Cites] Cell Calcium. 2007 Aug;42(2):145-56 [17572487.001]
  • [Cites] Mol Cell. 2000 Sep;6(3):539-50 [11030334.001]
  • [Cites] J Biol Chem. 2001 May 4;276(18):14814-20 [11278575.001]
  • [Cites] J Biol Chem. 2001 Jan 26;276(4):2313-6 [11096121.001]
  • [Cites] Eur J Immunol. 2001 Aug;31(8):2487-96 [11500833.001]
  • [Cites] Mol Cell Biol. 2002 Dec;22(23):8144-54 [12417718.001]
  • [Cites] J Exp Med. 2003 Jun 2;197(11):1453-65 [12782712.001]
  • [Cites] Genes Dev. 2003 Sep 15;17(18):2205-32 [12975316.001]
  • [Cites] Curr Opin Immunol. 2003 Dec;15(6):639-46 [14630197.001]
  • [Cites] Curr Med Chem. 2004 Apr;11(8):997-1007 [15078162.001]
  • [Cites] ACS Chem Biol. 2007 Oct 19;2(10):674-84 [18041817.001]
  • [Cites] J Biol Chem. 2007 Dec 28;282(52):37669-77 [17977829.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 25;101(21):8126-31 [15143214.001]
  • [Cites] Nat Rev Immunol. 2004 Oct;4(10):787-99 [15459670.001]
  • [Cites] Nature. 2004 Oct 21;431(7011):1007-11 [15496927.001]
  • [Cites] Eur J Immunol. 1981 Apr;11(4):317-23 [6166481.001]
  • [Cites] J Immunol. 1989 Jun 1;142(11):3796-802 [2541201.001]
  • [Cites] J Immunol. 1990 Apr 1;144(7):2659-64 [1690774.001]
  • [Cites] J Immunol. 1990 May 15;144(10):3891-7 [1692065.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6229-33 [1712484.001]
  • [Cites] Immunol Today. 1992 Jun;13(6):195-7 [1320890.001]
  • [Cites] J Biol Chem. 1993 Dec 5;268(34):25846-56 [7503989.001]
  • [Cites] J Biol Chem. 1994 Feb 25;269(8):5918-25 [8119935.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11246-50 [7526393.001]
  • [Cites] J Biol Chem. 1995 Jul 7;270(27):16333-8 [7608202.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11205-9 [7479966.001]
  • [Cites] Biochem J. 1995 Nov 15;312 ( Pt 1):145-50 [7492304.001]
  • [Cites] Mol Biol Cell. 1995 Sep;6(9):1145-58 [8534912.001]
  • [Cites] J Immunol. 1996 Mar 1;156(5):1942-5 [8596048.001]
  • [Cites] Mol Cell Biol. 1996 Apr;16(4):1471-8 [8657120.001]
  • [Cites] J Exp Med. 1996 Jul 1;184(1):71-9 [8691151.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8907-12 [8799126.001]
  • [Cites] Science. 1997 Jan 31;275(5300):665-8 [9005852.001]
  • [Cites] Nature. 1997 Apr 24;386(6627):855-8 [9126747.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6358-63 [9177222.001]
  • [Cites] Mol Biol Cell. 1998 Feb;9(2):483-96 [9450969.001]
  • [Cites] EMBO J. 1998 Apr 1;17(7):1961-72 [9524119.001]
  • [Cites] Nature. 1998 Apr 30;392(6679):933-6 [9582075.001]
  • [Cites] Nature. 1998 Apr 30;392(6679):936-41 [9582076.001]
  • [Cites] J Leukoc Biol. 1999 Mar;65(3):321-9 [10080534.001]
  • [Cites] Nat Immunol. 2005 Feb;6(2):135-42 [15662442.001]
  • [Cites] Nat Rev Immunol. 2005 Jun;5(6):472-84 [15928679.001]
  • [Cites] Nat Rev Immunol. 2006 Mar;6(3):218-30 [16470226.001]
  • [Cites] J Immunol. 2006 Nov 15;177(10):6667-74 [17082579.001]
  • [Cites] Immunity. 2000 Jul;13(1):25-35 [10933392.001]
  • (PMID = 19540596.001).
  • [ISSN] 1872-9142
  • [Journal-full-title] Molecular immunology
  • [ISO-abbreviation] Mol. Immunol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 DE000696-09; United States / Intramural NIH HHS / / Z99 DE999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens; 0 / Intracellular Signaling Peptides and Proteins; 0 / NFATC Transcription Factors; 0 / RNA, Small Interfering; 0 / Receptors, IgE; 0 / Tumor Necrosis Factor-alpha; 147336-22-9 / Green Fluorescent Proteins; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Syk kinase; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ NIHMS125588; NLM/ PMC2717025
  •  go-up   go-down


42. Horny HP, Sotlar K, Stellmacher F, Krokowski M, Agis H, Schwartz LB, Valent P: The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol; 2006 Mar;59(3):298-302
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: Compact tryptase-positive round cell infiltrates of the bone marrow (TROCI-BM) are very rare histopathological findings and may pose challenging problems with regard to the cell type involved (either mast cells or basophilic granulocytes) and the exact diagnosis.
  • METHODS: A selected panel of immunohistochemical markers against mast cell and basophil related antigens, including CD25, CD34, CD117/Kit, and the 2D7 antigen (which is found only in basophilic granulocytes) on a total of 410 routinely processed bone marrow biopsy specimens (including 88 cases of systemic mastocytosis (SM), 20 cases of chronic myeloid leukaemia (CML), 92 cases of myeloid neoplasms other than CML, and 210 controls with normal/reactive bone marrows).
  • RESULTS: In total, 17 cases with TROCI-BM could be identified: 11 SM (including two cases of well-differentiated SM and two mast cell leukaemias; MCL), 2 myelomastocytic leukaemia (MML), 2 CML with excess of basophils (secondary basophilic leukaemia (CMLba)), and 2 tryptase positive acute myeloid leukaemia (AML).
  • The basophil specific antigen 2D7 was only detected in CD34/Kit negative TROCI-BM cells in two patients with CMLba.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Basophils / chemistry. Biomarkers / analysis. Cell Lineage. Female. Humans. Immunohistochemistry / methods. Immunophenotyping. Leukemia, Mast-Cell / diagnosis. Male. Mast Cells / chemistry. Middle Aged. Point Mutation. Proto-Oncogene Proteins c-kit / genetics. Receptors, Interleukin-2 / analysis. Retrospective Studies. Tryptases

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Leuk Lymphoma. 2000 May;37(5-6):473-86 [11042508.001]
  • [Cites] Am J Surg Pathol. 1998 Sep;22(9):1132-40 [9737247.001]
  • [Cites] Leuk Res. 2001 Jul;25(7):543-51 [11377679.001]
  • [Cites] Leuk Res. 2001 Jul;25(7):595-602 [11377685.001]
  • [Cites] Leuk Res. 2001 Jul;25(7):603-25 [11377686.001]
  • [Cites] Hum Pathol. 2001 May;32(5):545-52 [11381374.001]
  • [Cites] Blood. 2001 Oct 1;98(7):2200-9 [11568008.001]
  • [Cites] Blood. 2001 Oct 15;98(8):2580-3 [11588060.001]
  • [Cites] Int Arch Allergy Immunol. 2002 Feb;127(2):115-7 [11919419.001]
  • [Cites] Leuk Lymphoma. 2002 Mar;43(3):575-82 [12002761.001]
  • [Cites] Hematol J. 2002;3(2):90-4 [12032870.001]
  • [Cites] Leuk Res. 2002 Nov;26(11):979-84 [12363464.001]
  • [Cites] Leuk Lymphoma. 2002 Dec;43(12):2257-61 [12613510.001]
  • [Cites] Blood. 2004 Apr 15;103(8):3222-5 [15070706.001]
  • [Cites] Am J Surg Pathol. 2004 Oct;28(10):1319-25 [15371947.001]
  • [Cites] Br J Haematol. 1976 Aug;33(4):451-8 [188440.001]
  • [Cites] Am J Clin Pathol. 1981 Jan;75(1):34-8 [7457427.001]
  • [Cites] J Histochem Cytochem. 1981 Apr;29(4):577-80 [6166661.001]
  • [Cites] Pathol Res Pract. 1985 Mar;179(4-5):439-61 [2582403.001]
  • [Cites] Hum Pathol. 1985 Aug;16(8):808-14 [3860469.001]
  • [Cites] Ann Intern Med. 1985 Oct;103(4):620-5 [3862359.001]
  • [Cites] J Invest Dermatol. 1991 Mar;96(3):2S-4S [2002248.001]
  • [Cites] Blood. 1994 Dec 15;84(12):4322-32 [7527672.001]
  • [Cites] J Immunol. 1995 Jun 15;154(12):6548-55 [7759888.001]
  • [Cites] J Pathol. 1995 Oct;177(2):139-46 [7490680.001]
  • [Cites] Leuk Lymphoma. 1996 Jul;22(3-4):187-204 [8819068.001]
  • [Cites] Mod Pathol. 1996 Oct;9(10):982-8 [8902835.001]
  • [Cites] Blood. 1998 Apr 15;91(8):2731-6 [9531582.001]
  • [Cites] Leuk Res. 2001 Jul;25(7):537-41 [11377678.001]
  • (PMID = 16505282.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Receptors, Interleukin-2; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 3.4.21.- / Serine Endopeptidases; EC 3.4.21.59 / Tryptases
  • [Other-IDs] NLM/ PMC1860329
  •  go-up   go-down


43. Qian W, Zhang X, Li B, Zhang D, Tong Q, Chen L, Zheng L, Kou G, Wang H, Hou S, Guo Y: Development and characterization of a novel anti-IgE monoclonal antibody. Biochem Biophys Res Commun; 2010 May 14;395(4):547-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Importantly, 7A5 was able to inhibit IgE-induced histamine release of basophilic leukemia cells.

  • Immune Epitope Database and Analysis Resource. gene/protein/disease-specific - Related Immune Epitope Information .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20394728.001).
  • [ISSN] 1090-2104
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Anti-Idiotypic; 0 / Antibodies, Monoclonal; 0 / Peptide Library; 0 / Peptides; 0 / Receptors, IgE; 0 / anti-IgE antibodies; 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


44. Agarwal R, Gupta R, Bakhshi S, Sharma A: Unusual cytochemical reactivity for toluidine blue in granular acute lymphoblastic leukemia: a report of two rare cases. Turk J Haematol; 2010 Mar 5;27(1):43-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual cytochemical reactivity for toluidine blue in granular acute lymphoblastic leukemia: a report of two rare cases.
  • Azurophilic granulation of blasts is a feature of acute myeloid leukemia (AML).
  • Granular acute lymphoblastic leukemia (ALL) may mimic AML due to the presence of cytoplasmic granules in lymphoblasts, but cytochemistry and immunophenotyping are helpful in making the correct diagnosis.
  • Toluidine blue (TB) is a metachromatic dye, which stains basophils and myeloid blasts that exhibit basophilic differentiation.
  • This report of two rare case highlight the reactivity of lymphoblasts with TB not hitherto described and the importance of a detailed diagnostic work-up in acute leukemia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27265798.001).
  • [ISSN] 1300-7777
  • [Journal-full-title] Turkish journal of haematology : official journal of Turkish Society of Haematology
  • [ISO-abbreviation] Turk J Haematol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


45. Mason MJ, Simpson AK, Mahaut-Smith MP, Robinson HP: The interpretation of current-clamp recordings in the cell-attached patch-clamp configuration. Biophys J; 2005 Jan;88(1):739-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Membrane potential measurements across intact cell-attached patches in rat basophilic leukemia cells and rat megakaryocytes revealed a surprisingly high degree of accuracy and demonstrated the ability of this noninvasive technique to follow dynamic changes in potential in nonexcitable cells.
  • [MeSH-minor] Adenosine Diphosphate / chemistry. Animals. Cell Line. Cell Line, Tumor. Electrodes. Leukemia / metabolism. Male. Megakaryocytes / metabolism. Membrane Potentials. Models, Theoretical. Rats. Rats, Wistar. Sodium Chloride / pharmacology

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SODIUM CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Membr Biol. 1999 Jul 1;170(1):79-87 [10398762.001]
  • [Cites] J Gen Physiol. 1988 Aug;92(2):145-59 [2459299.001]
  • [Cites] J Neurosci. 1985 Jul;5(7):1886-95 [4020423.001]
  • [Cites] J Neurosci. 1989 Jun;9(6):2182-90 [2723769.001]
  • [Cites] J Gen Physiol. 1990 Feb;95(2):205-27 [2106571.001]
  • [Cites] J Membr Biol. 1990 Jun;116(2):139-48 [2116524.001]
  • [Cites] J Neurosci Methods. 1991 Mar;37(1):15-26 [2072734.001]
  • [Cites] Am J Physiol. 1992 Jan;262(1 Pt 1):C84-90 [1733236.001]
  • [Cites] J Membr Biol. 1992 Mar;126(2):171-81 [1593616.001]
  • [Cites] J Biol Chem. 1993 Jan 5;268(1):168-74 [7677993.001]
  • [Cites] J Physiol. 1993 Oct;470:731-49 [8308753.001]
  • [Cites] J Biol Chem. 1994 May 20;269(20):14813-9 [8182088.001]
  • [Cites] J Gen Physiol. 1994 Aug;104(2):287-309 [7807050.001]
  • [Cites] J Biol Chem. 1995 Jul 14;270(28):16638-44 [7542650.001]
  • [Cites] J Gen Physiol. 1995 Jun;105(6):765-94 [7561743.001]
  • [Cites] J Membr Biol. 1996 Oct;153(3):217-31 [8849417.001]
  • [Cites] Trends Neurosci. 1996 Dec;19(12):530-4 [8961481.001]
  • [Cites] Biophys J. 1998 Jan;74(1):48-53 [9449308.001]
  • [Cites] Biophys J. 1998 Feb;74(2 Pt 1):831-42 [9533695.001]
  • [Cites] J Physiol. 1999 Mar 1;515 ( Pt 2):385-90 [10050006.001]
  • [Cites] J Physiol. 2000 Apr 15;524 Pt 2:437-46 [10766924.001]
  • [Cites] Biophys J. 2001 Aug;81(2):1163-70 [11463657.001]
  • [Cites] Biophys J. 2003 Apr;84(4):2646-54 [12668473.001]
  • [Cites] J Ultrastruct Res. 1968 Sep;24(5):412-33 [4179476.001]
  • [Cites] Proc Natl Acad Sci U S A. 1976 Aug;73(8):2682-6 [1066680.001]
  • [Cites] Pflugers Arch. 1978 Jul 18;375(2):219-28 [567789.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Feb;76(2):650-4 [284390.001]
  • [Cites] Biochim Biophys Acta. 1979 Apr 19;552(3):552-7 [87222.001]
  • [Cites] J Physiol. 1979 Mar;288:481-507 [469731.001]
  • [Cites] Annu Rev Biophys Bioeng. 1979;8:47-68 [383007.001]
  • [Cites] Biochim Biophys Acta. 1980;595(1):15-30 [6153065.001]
  • [Cites] Pflugers Arch. 1981 Aug;391(2):85-100 [6270629.001]
  • [Cites] J Physiol. 1982 Oct;331:577-97 [6296371.001]
  • [Cites] J Gen Physiol. 1984 Oct;84(4):565-84 [6334129.001]
  • [Cites] J Gen Physiol. 1986 Sep;88(3):349-68 [2428921.001]
  • [Cites] Pflugers Arch. 1988 Feb;411(2):204-11 [2451806.001]
  • [Cites] Biophys J. 1988 May;53(5):785-94 [3390520.001]
  • [Cites] Acta Anat (Basel). 1957;29(3):267-90 [13434640.001]
  • (PMID = 15516522.001).
  • [ISSN] 0006-3495
  • [Journal-full-title] Biophysical journal
  • [ISO-abbreviation] Biophys. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 451W47IQ8X / Sodium Chloride; 61D2G4IYVH / Adenosine Diphosphate
  • [Other-IDs] NLM/ PMC1305049
  •  go-up   go-down


46. Kaneko M, Kanesaka M, Yoneyama M, Tominaga T, Jirillo E, Kumazawa Y: Inhibitory effects of fermented grape marc from Vitis vinifera Negroamaro on antigen-induced degranulation. Immunopharmacol Immunotoxicol; 2010 Sep;32(3):454-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the antiallergic effects of fermented grape marc from Negroamaro (N-FGM), we examined antigen (Ag)-induced degranulation of rat basophilic leukemia (RBL-2H3) cells.
  • [MeSH-minor] Animals. Antigens / immunology. Basophil Degranulation Test. Fermentation. Immunoglobulin E / immunology. Intracellular Signaling Peptides and Proteins / metabolism. Phosphorylation. Protein-Tyrosine Kinases / metabolism. Rats. Syk Kinase. Tumor Cells, Cultured

  • Hazardous Substances Data Bank. QUERCETIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20100066.001).
  • [ISSN] 1532-2513
  • [Journal-full-title] Immunopharmacology and immunotoxicology
  • [ISO-abbreviation] Immunopharmacol Immunotoxicol
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BB/D008123/1
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Antigens; 0 / Intracellular Signaling Peptides and Proteins; 37341-29-0 / Immunoglobulin E; 9IKM0I5T1E / Quercetin; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.2 / Syk Kinase; EC 2.7.10.2 / Syk protein, rat
  •  go-up   go-down


47. Lahortiga I, Akin C, Cools J, Wilson TM, Mentens N, Arthur DC, Maric I, Noel P, Kocabas C, Marynen P, Lessin LS, Wlodarska I, Robyn J, Metcalfe DD: Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion. Haematologica; 2008 Jan;93(1):49-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion.
  • [MeSH-major] Gene Expression Regulation, Leukemic. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics. Mastocytosis, Systemic / drug therapy. Mastocytosis, Systemic / genetics. Oncogene Proteins, Fusion / genetics. Piperazines / pharmacology. Pyrimidines / pharmacology. Receptor, Platelet-Derived Growth Factor beta / chemistry

  • Genetic Alliance. consumer health - Mast cell disease.
  • Genetic Alliance. consumer health - Systemic mastocytosis.
  • MedlinePlus Health Information. consumer health - Chronic Myeloid Leukemia.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18166785.001).
  • [ISSN] 1592-8721
  • [Journal-full-title] Haematologica
  • [ISO-abbreviation] Haematologica
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Benzamides; 0 / Oncogene Proteins, Fusion; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor beta
  •  go-up   go-down


48. Nugroho AE, Ikawati Z, Sardjiman, Maeyama K: Effects of benzylidenecyclopentanone analogues of curcumin on histamine release from mast cells. Biol Pharm Bull; 2009 May;32(5):842-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study, fourteen benzylidenecyclopentanone analogues of curcumin were studied for their effects on histamine release from rat basophilic leukemia (RBL-2H3) cells.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CYCLOPENTANONE .
  • Hazardous Substances Data Bank. CURCUMIN .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19420752.001).
  • [ISSN] 0918-6158
  • [Journal-full-title] Biological & pharmaceutical bulletin
  • [ISO-abbreviation] Biol. Pharm. Bull.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Benzylidene Compounds; 0 / Cyclopentanes; 220W81TN3S / cyclopentanone; IT942ZTH98 / Curcumin; SY7Q814VUP / Calcium
  •  go-up   go-down


49. Jolly PS, Bektas M, Watterson KR, Sankala H, Payne SG, Milstien S, Spiegel S: Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors. Blood; 2005 Jun 15;105(12):4736-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Surprisingly, overexpression of SphK1 in rat basophilic leukemia (RBL)-2H3 mast cells impaired degranulation as well as migration toward antigen.

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2002 Sep 20;277(38):35257-62 [12124383.001]
  • [Cites] Annu Rev Immunol. 2005;23:127-59 [15771568.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 May;4(5):397-407 [12728273.001]
  • [Cites] Prog Lipid Res. 2003 Jul;42(4):344-57 [12790117.001]
  • [Cites] EMBO J. 2003 Oct 15;22(20):5491-500 [14532121.001]
  • [Cites] J Biol Chem. 2003 Nov 21;278(47):46452-60 [12963721.001]
  • [Cites] Nature. 2004 Jan 22;427(6972):355-60 [14737169.001]
  • [Cites] Circ Res. 2004 Apr 2;94(6):724-34 [15059942.001]
  • [Cites] J Exp Med. 2004 Apr 5;199(7):959-70 [15067032.001]
  • [Cites] Am J Physiol Cell Physiol. 2004 May;286(5):C1130-8 [15075212.001]
  • [Cites] Semin Cell Dev Biol. 2004 Jun;15(3):309-23 [15125894.001]
  • [Cites] J Biol Chem. 2004 May 14;279(20):20555-8 [15023998.001]
  • [Cites] Curr Opin Cell Biol. 2004 Apr;16(2):162-8 [15196559.001]
  • [Cites] Nat Immunol. 2004 Jul;5(7):713-20 [15184895.001]
  • [Cites] J Leukoc Biol. 2004 Jul;76(1):30-5 [14982946.001]
  • [Cites] Nat Rev Cancer. 2004 Aug;4(8):604-16 [15286740.001]
  • [Cites] Nature. 1993 Oct 7;365(6446):557-60 [8413613.001]
  • [Cites] J Cell Biol. 1999 Nov 1;147(3):545-58 [10545499.001]
  • [Cites] Cancer Res. 1999 Dec 15;59(24):6185-91 [10626811.001]
  • [Cites] J Biol Chem. 2000 Oct 27;275(43):33945-50 [10944534.001]
  • [Cites] Curr Biol. 2000 Nov 30;10(23):1527-30 [11114522.001]
  • [Cites] J Neurochem. 2001 Mar;76(5):1573-84 [11238741.001]
  • [Cites] FASEB J. 2001 Dec;15(14):2649-59 [11726541.001]
  • [Cites] J Biol Chem. 2002 Feb 22;277(8):6667-75 [11741921.001]
  • [Cites] Science. 2002 Apr 12;296(5566):346-9 [11923495.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):17255-62 [11856736.001]
  • [Cites] J Biol Chem. 2002 Jun 14;277(24):21453-7 [11967257.001]
  • [Cites] Nature. 1996 Apr 18;380(6575):634-6 [8602265.001]
  • [Cites] Nature. 1996 Jun 27;381(6585):800-3 [8657285.001]
  • [Cites] J Biol Chem. 1998 May 15;273(20):12576-83 [9575218.001]
  • [Cites] J Immunol. 1998 May 15;160(10):5136-44 [9590266.001]
  • [Cites] Anal Biochem. 1999 Jul 15;272(1):80-6 [10405296.001]
  • [Cites] J Exp Med. 1999 Jul 5;190(1):1-8 [10429665.001]
  • [Cites] J Biol Chem. 2003 Feb 21;278(8):6282-90 [12480944.001]
  • (PMID = 15741218.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AIS0094; United States / NCI NIH HHS / CA / P30 CA16059
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cross-Linking Reagents; 0 / Culture Media, Serum-Free; 0 / Ligands; 0 / Proto-Oncogene Proteins; 0 / Receptors, IgE; 0 / Receptors, Lysosphingolipid; 37341-29-0 / Immunoglobulin E; 37589-80-3 / Guanosine 5'-O-(3-Thiotriphosphate); EC 2.7.1.- / Phosphotransferases (Alcohol Group Acceptor); EC 2.7.1.- / sphingosine kinase; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3; EC 2.7.11.24 / p38 Mitogen-Activated Protein Kinases; EC 3.6.5.1 / GTP-Binding Protein alpha Subunit, Gi2; EC 3.6.5.1 / GTP-Binding Protein alpha Subunits, Gi-Go; EC 3.6.5.1 / GTP-Binding Protein alpha Subunits, Gq-G11; EC 3.6.5.1 / Gnai2 protein, rat; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ PMC1894993
  •  go-up   go-down


50. Tsai MH, Yang CP, Chung HT, Shih LY: Acute myeloid leukemia in a young girl presenting with mediastinal granulocytic sarcoma invading pericardium and causing superior vena cava syndrome. J Pediatr Hematol Oncol; 2009 Dec;31(12):980-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute myeloid leukemia in a young girl presenting with mediastinal granulocytic sarcoma invading pericardium and causing superior vena cava syndrome.
  • A 1-year-4-month-old girl who presented with pericardial effusion and superior vena cava (SVC) syndrome caused by a mediastinal mass was later proved to be a case of acute myeloid leukemia (AML) with mixed-lineage leukemia-gene translocation.
  • The unusual presentation and the giant blasts with basophilic vacuolated cytoplasm had led to initial misdiagnosis of mediastinal lymphoma.
  • She developed progressive SVC syndrome, unresolved pericardial effusion, and extensive leukemia cutis after initial induction therapy.
  • To our knowledge, this is the first reported case of childhood acute myeloid leukemia presenting with mediastinal granulocytic sarcoma causing pericardium invasion and SVC syndrome.
  • [MeSH-major] Leukemia, Myeloid, Acute / pathology. Mediastinal Neoplasms / diagnosis. Pericardium / pathology. Sarcoma, Myeloid / diagnosis. Superior Vena Cava Syndrome / diagnosis


51. Atiya-Nasagi Y, Cohen H, Medalia O, Fukudan M, Sagi-Eisenberg R: O-glycosylation is essential for intracellular targeting of synaptotagmins I and II in non-neuronal specialized secretory cells. J Cell Sci; 2005 Apr 1;118(Pt 7):1363-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have examined the trafficking of synaptotagmin (Syt) I and II in the mast cell line rat basophilic leukemia (RBL-2H3).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15755799.001).
  • [ISSN] 0021-9533
  • [Journal-full-title] Journal of cell science
  • [ISO-abbreviation] J. Cell. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Membrane Glycoproteins; 0 / Membrane Proteins; 0 / Nerve Tissue Proteins; 0 / Synaptotagmin II; 0 / Syt2 protein, rat; 134193-27-4 / Synaptotagmins; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


52. Horny HP, Sotlar K, Valent P: Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review. Pathobiology; 2010;77(4):169-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reliable immunohistochemical markers for the diagnosis and grading of SM have been established, but various differential diagnoses including myeloproliferative neoplasms, basophilic and eosinophilic leukemias may be very difficult to delineate.
  • Even more challenging is the recognition of hematological neoplasms with signs of mast cell differentiation but not fulfilling diagnostic criteria for SM, especially the rare myelomastocytic leukemia.
  • This hypogranulation can be regarded as cellular atypia and may lead to the misdiagnosis aspect of monocytic leukemia or histiocytic neoplasm.

  • Genetic Alliance. consumer health - Mast cell disease.
  • Genetic Alliance. consumer health - Systemic mastocytosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20616612.001).
  • [ISSN] 1423-0291
  • [Journal-full-title] Pathobiology : journal of immunopathology, molecular and cellular biology
  • [ISO-abbreviation] Pathobiology
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  •  go-up   go-down


53. Brimo F, Popradi G, Michel RP, Auger M: Primary effusion lymphoma involving three body cavities. Cytojournal; 2009;6:21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An examination of the fluid by cytology showed large atypical lymphocytes with abundant basophilic cytoplasm, either central or eccentric nuclei having irregular outlines, and multiple prominent nucleoli.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1995 May 4;332(18):1186-91 [7700311.001]
  • [Cites] Eur J Haematol. 2003 Jul;71(1):62-7 [12801300.001]
  • [Cites] Am J Surg Pathol. 1998 Apr;22(4):493-9 [9537479.001]
  • [Cites] Adv Cancer Res. 1999;76:121-60 [10218100.001]
  • [Cites] Eur Respir J. 1999 Nov;14(5):1231-4 [10596717.001]
  • [Cites] Blood. 2001 Feb 1;97(3):744-51 [11157493.001]
  • [Cites] AIDS. 2001 Jan 26;15(2):280-2 [11216942.001]
  • [Cites] Mod Pathol. 2002 Sep;15(9):944-50 [12218212.001]
  • [Cites] Mod Pathol. 2004 Apr;17(4):456-60 [14990970.001]
  • [Cites] Acta Cytol. 2004 May-Jun;48(3):425-30 [15192964.001]
  • [Cites] J Mol Diagn. 2005 Feb;7(1):17-27 [15681470.001]
  • [Cites] Am J Surg Pathol. 2005 May;29(5):647-52 [15832089.001]
  • [Cites] AIDS. 2006 Jul 13;20(11):1567-9 [16847420.001]
  • [Cites] J Infect Dis. 2008 Jul 1;198(1):23-30 [18491970.001]
  • [Cites] APMIS. 2009 Mar;117(3):222-9 [19245595.001]
  • [Cites] Science. 1994 Dec 16;266(5192):1865-9 [7997879.001]
  • [Cites] Blood. 1996 Jul 15;88(2):645-56 [8695812.001]
  • [Cites] Br J Haematol. 1996 Sep;94(3):533-43 [8790156.001]
  • [Cites] Diagn Cytopathol. 1997 Aug;17(2):134-7 [9258621.001]
  • [Cites] Am J Surg Pathol. 1998 Dec;22(12):1528-37 [9850179.001]
  • [Cites] Arch Pathol Lab Med. 1999 Mar;123(3):257-60 [10086517.001]
  • [Cites] Acta Cytol. 1999 May-Jun;43(3):498-502 [10349390.001]
  • [Cites] Arch Pathol Lab Med. 2000 May;124(5):753-5 [10782162.001]
  • [Cites] Am J Hematol. 2000 Dec;65(4):310-4 [11074561.001]
  • [Cites] Br J Haematol. 2000 Dec;111(4):1112-5 [11167749.001]
  • [Cites] Arch Pathol Lab Med. 2001 Sep;125(9):1246-8 [11520284.001]
  • [Cites] Am J Clin Pathol. 2004 Mar;121(3):330-4 [15023036.001]
  • [Cites] Am J Surg Pathol. 2004 Nov;28(11):1401-16 [15489644.001]
  • [Cites] Leukemia. 2005 Mar;19(3):473-6 [15674353.001]
  • [Cites] Clin Infect Dis. 2005 Apr 1;40(7):1022-7 [15824995.001]
  • [Cites] Br J Haematol. 2005 Sep;130(5):662-70 [16115121.001]
  • [Cites] Acta Haematol. 2007;117(3):132-44 [17135726.001]
  • [Cites] Cancer. 2008 Aug 25;114(4):225-7 [18473348.001]
  • [Cites] AIDS. 2008 Jun 19;22(10):1236-7 [18525275.001]
  • [Cites] Blood. 2003 May 15;101(10):4115-21 [12531789.001]
  • [Cites] Hum Pathol. 1997 Jan;28(1):101-4 [9013840.001]
  • (PMID = 19876384.001).
  • [ISSN] 1742-6413
  • [Journal-full-title] CytoJournal
  • [ISO-abbreviation] Cytojournal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2762694
  • [Keywords] NOTNLM ; Effusion / Epstein–Barr virus / human herpes virus-8 / lymphoma
  •  go-up   go-down


54. Papapetrou EP, Korkola JE, Sadelain M: A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells; 2010 Feb;28(2):287-96
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These chimeras showed abnormal patterns of erythroid differentiation primarily affecting the proerythroblast to basophilic erythroblast transition, coinciding with the stage where expression of the miRNA cluster is dramatically induced and posttranscriptional gene regulation becomes prominent.
  • [MeSH-minor] Animals. Erythropoiesis / genetics. Erythropoiesis / physiology. Flow Cytometry. Leukemia, Erythroblastic, Acute. Mice. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19911427.001).
  • [ISSN] 1549-4918
  • [Journal-full-title] Stem cells (Dayton, Ohio)
  • [ISO-abbreviation] Stem Cells
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / HL 57612; United States / NCI NIH HHS / CA / P01 CA059350
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MicroRNAs
  •  go-up   go-down


55. Ye YQ, Koshino H, Onose J, Negishi C, Yoshikawa K, Abe N, Takahashi S: Structural revision of thelephantin G by total synthesis and the inhibitory activity against TNF-alpha production. J Org Chem; 2009 Jun 19;74(12):4642-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compound 2 strongly inhibited TNF (tumor necrosis factor)-alpha production in rat basophilic leukemia (RBL-2H3) cells: IC(50) = 3.5 nM, while a mixture of 1 and its regioisomer 15 showed no such activity.
  • [MeSH-minor] Animals. Cell Line, Tumor. Leukemia, Basophilic, Acute / metabolism. Nuclear Magnetic Resonance, Biomolecular. Rats. Stereoisomerism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19453155.001).
  • [ISSN] 1520-6904
  • [Journal-full-title] The Journal of organic chemistry
  • [ISO-abbreviation] J. Org. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Terphenyl Compounds; 0 / Tumor Necrosis Factor-alpha
  •  go-up   go-down


56. Blonski WC, Katzka DA, Lichtenstein GR, Metz DC: Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease. Eur J Gastroenterol Hepatol; 2005 Apr;17(4):441-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
  • Many gastric acid hypersecretory states (basal acid output of greater than 15.0 mEq/h) exist for which the etiology is known, such as Zollinger-Ellison syndrome, systemic mastocytosis, antral exclusion, antral predominant Helicobacter pylori gastritis (antral G cell hyperplasia), chronic gastric outlet obstruction, short gut syndrome and basophilic leukemias.

  • Genetic Alliance. consumer health - Crohn Disease.
  • Genetic Alliance. consumer health - Zollinger-Ellison syndrome.
  • MedlinePlus Health Information. consumer health - Crohn's Disease.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. OMEPRAZOLE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Eur J Gastroenterol Hepatol. 2005 Dec;17(12):1433 [16292103.001]
  • [CommentIn] Eur J Gastroenterol Hepatol. 2005 Sep;17(9):1001 [16093882.001]
  • (PMID = 15756097.001).
  • [ISSN] 0954-691X
  • [Journal-full-title] European journal of gastroenterology & hepatology
  • [ISO-abbreviation] Eur J Gastroenterol Hepatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Ulcer Agents; 0 / Gastrins; KG60484QX9 / Omeprazole
  • [Number-of-references] 28
  •  go-up   go-down


57. Venizelos ID, Klonizakis I, Vlahaki E, Haralambidou S, Tatsiou Z, Ioannidou E: Skin relapse of acute myeloid leukemia associated with trisomy 8. Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun;16(2):77-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skin relapse of acute myeloid leukemia associated with trisomy 8.
  • Acute myeloid leukemia (AML) is a morphologically diverse group of hematopoietic malignancies characterized by proliferation of immature cells that arise in the myeloid progenitor cells of the bone marrow.
  • A skin nodule from the right arm was excised and histology showed a diffuse infiltration of the dermis consisting of large cells with round to oval nuclei and little basophilic cytoplasm.
  • [MeSH-major] Chromosomes, Human, Pair 8. Leukemia, Myeloid, Acute / pathology. Skin Neoplasms / pathology. Trisomy

  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17992463.001).
  • [ISSN] 1318-4458
  • [Journal-full-title] Acta dermatovenerologica Alpina, Pannonica, et Adriatica
  • [ISO-abbreviation] Acta Dermatovenerol Alp Pannonica Adriat
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Slovenia
  •  go-up   go-down


58. Hunter MJ, Iodice MW, Pathak AK, Street MA, Helm BA: Characterization of an early signaling defect following Fc epsilonRI activation in the canine mastocytoma cell line, C2. Mol Immunol; 2009 Mar;46(6):1260-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A comparison of IgE recognition by cognate receptors expressed on the C2 canine mastocytoma cell line with analogous events in a rat basophilic leukemia cell line transfected with the alpha-chain subunit of the canine high-affinity IgE receptor using flow cytometry show that canine IgE recognizes the alpha-chain of its cognate receptor on both cell lines.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19135724.001).
  • [ISSN] 1872-9142
  • [Journal-full-title] Molecular immunology
  • [ISO-abbreviation] Mol. Immunol.
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BBSQ/Q/2005/06706
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Intracellular Signaling Peptides and Proteins; 0 / Receptors, IgE; 37H9VM9WZL / Calcimycin; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Syk kinase; EC 3.2.1.52 / beta-N-Acetylhexosaminidases
  •  go-up   go-down


59. Knipping K, van Esch EC, Wijering SC, van der Heide S, Dubois AE, Garssen J: In vitro and in vivo anti-allergic effects of Arctium lappa L. Exp Biol Med (Maywood); 2008 Nov;233(11):1469-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AL was selected out of 10,000 herbal extracts in a set-up for high throughput screening in which the degree of degranulation was monitored by the release of beta-hexosaminidase from rat basophil leukemia (RBL-2H3) cells.
  • [MeSH-minor] Animals. Basophil Degranulation Test. Basophils / drug effects. Basophils / metabolism. Chemical Fractionation. Chromatography, High Pressure Liquid. Ear Diseases / chemically induced. Ear Diseases / drug therapy. Edema / chemically induced. Edema / drug therapy. Humans. Leukocytes, Mononuclear / drug effects. Leukocytes, Mononuclear / metabolism. Leukotrienes / biosynthesis. Mice. Rats

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18703753.001).
  • [ISSN] 1535-3702
  • [Journal-full-title] Experimental biology and medicine (Maywood, N.J.)
  • [ISO-abbreviation] Exp. Biol. Med. (Maywood)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Anti-Inflammatory Agents; 0 / Leukotrienes; 0 / Plant Extracts
  •  go-up   go-down


60. Morikawa T, Xu F, Matsuda H, Yoshikawa M: Structures of novel norstilbene dimer, longusone A, and three new stilbene dimers, longusols A, B, and C, with antiallergic and radical scavenging activities from Egyptian natural medicine Cyperus longus. Chem Pharm Bull (Tokyo); 2010 Oct;58(10):1379-85
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among the isolates, longusol B (IC(50)=96 µM), luteolin (3.0 µM), resveratrol (17 µM), piceatannol (24 µM), and cassigarols E (84 µM) and G (84 µM) were found to inhibit the release of β-hexosaminidase, as a marker of antigen-induced degranulations, in rat basophilic leukemia (RBL-2H3) cells.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20930408.001).
  • [ISSN] 1347-5223
  • [Journal-full-title] Chemical & pharmaceutical bulletin
  • [ISO-abbreviation] Chem. Pharm. Bull.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Free Radical Scavengers; 0 / Stilbenes; EC 3.2.1.52 / beta-N-Acetylhexosaminidases
  •  go-up   go-down


61. Baumann MJ, Eggel A, Amstutz P, Stadler BM, Vogel M: DARPins against a functional IgE epitope. Immunol Lett; 2010 Oct 30;133(2):78-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, anti-IgE DARPins were shown to inhibit proinflammatory mediator release from rat basophilic leukemia cells expressing human high-affinity IgE receptors with higher efficacy than the monoclonal anti-IgE antibody omalizumab.

  • MedlinePlus Health Information. consumer health - Asthma.
  • Hazardous Substances Data Bank. Omalizumab .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 20673836.001).
  • [ISSN] 1879-0542
  • [Journal-full-title] Immunology letters
  • [ISO-abbreviation] Immunol. Lett.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies, Anti-Idiotypic; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / DARPin E2 79; 0 / Epitopes, B-Lymphocyte; 0 / Immunoglobulin Constant Regions; 0 / Recombinant Fusion Proteins; 2P471X1Z11 / Omalizumab; 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


62. Xue J, Zhao Q, Zhu L, Zhang W: Deglycosylation of FcalphaR at N58 increases its binding to IgA. Glycobiology; 2010 Jul;20(7):905-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Similar result was shown for N58Q-FcalphaR transfected RBL2H3, a rat basophilic leukemia cell line.

  • Hazardous Substances Data Bank. Glutamine .
  • Hazardous Substances Data Bank. ASPARAGINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20378933.001).
  • [ISSN] 1460-2423
  • [Journal-full-title] Glycobiology
  • [ISO-abbreviation] Glycobiology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Fc(alpha) receptor; 0 / Immunoglobulin A; 0 / Receptors, Fc; 0RH81L854J / Glutamine; 7006-34-0 / Asparagine
  •  go-up   go-down


63. Puri N, Roche PA: Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic; 2006 Nov;7(11):1482-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the role of lipid rafts in secretory granule exocytosis, we examined the raft association of SNARE proteins and SNARE complexes in rat basophilic leukemia (RBL) mast cells.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16984405.001).
  • [ISSN] 1398-9219
  • [Journal-full-title] Traffic (Copenhagen, Denmark)
  • [ISO-abbreviation] Traffic
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Dinitrophenols; 0 / Qa-SNARE Proteins; 0 / Receptors, IgE; 0 / SNARE Proteins; 0 / Serum Albumin, Bovine; 0 / Snap23 protein, rat; 0 / Snap25 protein, mouse; 0 / Synaptosomal-Associated Protein 25; 0 / Vesicle-Associated Membrane Protein 2; 0 / Vesicular Transport Proteins; 0 / dinitrophenyl-bovine serum albumin; 37341-29-0 / Immunoglobulin E; 9012-63-9 / Cholera Toxin
  •  go-up   go-down


64. Huelsenbeck J, Dreger S, Gerhard R, Barth H, Just I, Genth H: Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect Immun; 2007 Feb;75(2):801-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rat basophilic leukemia (RBL) cells were synchronized using the thymidine double-block technique.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochem Biophys Res Commun. 2000 Feb 24;268(3):784-9 [10679283.001]
  • [Cites] J Clin Invest. 1997 Oct 1;100(7):1734-41 [9312171.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 May 22;98(11):6192-7 [11353846.001]
  • [Cites] J Biol Chem. 2001 Oct 19;276(42):39123-31 [11509562.001]
  • [Cites] Int J Med Microbiol. 2001 Sep;291(4):243-50 [11680784.001]
  • [Cites] Carcinogenesis. 2002 Mar;23(3):521-8 [11895868.001]
  • [Cites] Cell Microbiol. 2002 Jul;4(7):425-34 [12102688.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2002 Oct;283(4):L830-8 [12225960.001]
  • [Cites] J Infect Dis. 2002 Nov 15;186(10):1438-47 [12404159.001]
  • [Cites] J Biol Chem. 2003 Feb 14;278(7):4847-53 [12475982.001]
  • [Cites] J Biol Chem. 2003 Mar 7;278(10):7956-63 [12496290.001]
  • [Cites] J Clin Microbiol. 2003 Mar;41(3):1118-25 [12624039.001]
  • [Cites] Trends Cell Biol. 2003 May;13(5):238-46 [12742167.001]
  • [Cites] Cell Microbiol. 2003 Nov;5(11):761-71 [14531892.001]
  • [Cites] Dev Biol. 2004 Jan 1;265(1):23-32 [14697350.001]
  • [Cites] J Biol Chem. 1997 Dec 5;272(49):30637-44 [9388198.001]
  • [Cites] Oncogene. 1997 Oct;15(18):2179-89 [9393976.001]
  • [Cites] J Cell Biol. 1998 Feb 9;140(3):627-36 [9456322.001]
  • [Cites] Biochemistry. 1998 Apr 14;37(15):5296-304 [9548761.001]
  • [Cites] Infect Immun. 1998 Jun;66(6):2660-5 [9596731.001]
  • [Cites] Infect Immun. 1998 Nov;66(11):5462-9 [9784558.001]
  • [Cites] Oncogene. 1999 Jan 7;18(1):47-57 [9926919.001]
  • [Cites] J Biol Chem. 1999 Apr 16;274(16):11046-52 [10196187.001]
  • [Cites] J Biol Chem. 1999 Oct 8;274(41):29050-6 [10506156.001]
  • [Cites] Rev Physiol Biochem Pharmacol. 2004;152:23-47 [15449191.001]
  • [Cites] J Vet Pharmacol Ther. 2004 Dec;27(6):491-502 [15601443.001]
  • [Cites] J Biol Chem. 2005 Jan 14;280(2):1499-505 [15531589.001]
  • [Cites] Clin Microbiol Rev. 2005 Apr;18(2):247-63 [15831824.001]
  • [Cites] J Immunol. 2005 May 15;174(10):6381-90 [15879139.001]
  • [Cites] Biochem J. 2005 Jul 1;389(Pt 1):197-206 [15796713.001]
  • [Cites] J Neurochem. 2005 Aug;94(4):1025-39 [16092944.001]
  • [Cites] Gastroenterology. 2005 Dec;129(6):1875-88 [16344056.001]
  • [Cites] Infect Immun. 2006 Jan;74(1):81-7 [16368960.001]
  • [Cites] FEBS Lett. 2006 Jun 12;580(14):3565-9 [16730714.001]
  • [Cites] Oncogene. 2004 Feb 5;23(5):1136-45 [14647415.001]
  • [Cites] J Cell Sci. 2004 Mar 15;117(Pt 8):1301-12 [15020670.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 May;5(5):355-66 [15122349.001]
  • [Cites] Mol Cell Biol. 2004 Jun;24(12):5565-76 [15169915.001]
  • [Cites] Infect Immun. 1992 Oct;60(10):4192-9 [1398930.001]
  • [Cites] J Med Microbiol. 1993 Jun;38(6):434-41 [8510136.001]
  • [Cites] Infect Immun. 1995 Apr;63(4):1421-6 [7890404.001]
  • [Cites] Oncogene. 1995 May 18;10(10):1935-45 [7539118.001]
  • [Cites] J Immunol. 1996 Jun 1;156(11):4146-53 [8666781.001]
  • [Cites] J Mol Biol. 2000 Sep 1;301(5):1091-5 [10966807.001]
  • (PMID = 17145947.001).
  • [ISSN] 0019-9567
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Bacterial Toxins; 0 / Caspase Inhibitors; 0 / Enzyme Inhibitors; 0 / Oligopeptides; 0 / acetyl-aspartyl-methionyl-glutaminyl-aspartyl-aldehyde; 0 / toxB protein, Clostridium difficile; EC 3.4.22.- / Caspase 3; EC 3.6.5.2 / cdc42 GTP-Binding Protein; EC 3.6.5.2 / rhoA GTP-Binding Protein; EC 3.6.5.2 / rhoB GTP-Binding Protein
  • [Other-IDs] NLM/ PMC1828479
  •  go-up   go-down


65. Radaelli E, Marchesi F, Patton V, Scanziani E: Diagnostic exercise: sudden death in a mouse with experimentally induced acute myeloid leukemia. Vet Pathol; 2009 Nov;46(6):1301-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic exercise: sudden death in a mouse with experimentally induced acute myeloid leukemia.
  • A 22-week-old female 129/SvEv mouse suddenly died in the context of an experiment aimed at defining the efficacy of valproic acid in a mouse model of PML/RARalpha-induced acute myeloid leukemia.
  • Histologic analysis confirmed the mouse as being affected by a progressive myeloid leukemia, with infiltration of the spleen, bone marrow, liver, kidneys, and lungs.
  • Variably sized intravascular clumps (emboli) of dense basophilic material admixed with necrotic or lytic neoplastic cells were also observed in multiple organs.
  • A positive reaction to Feulgen and Hoechst stain confirmed the high content in chromatin of these basophilic emboli.
  • Cleaved caspase-3 activity was demonstrated both in the leukemic infiltrates and among the intravascular necrotic or lytic neoplastic cells accompanying the basophilic emboli.
  • [MeSH-major] Leukemia, Myeloid, Acute / chemically induced. Tumor Lysis Syndrome / veterinary

  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. VALPROIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19605917.001).
  • [ISSN] 1544-2217
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 614OI1Z5WI / Valproic Acid
  •  go-up   go-down


66. Spendier K, Carroll-Portillo A, Lidke KA, Wilson BS, Timlin JA, Thomas JL: Distribution and dynamics of rat basophilic leukemia immunoglobulin E receptors (FcepsilonRI) on planar ligand-presenting surfaces. Biophys J; 2010 Jul 21;99(2):388-97
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distribution and dynamics of rat basophilic leukemia immunoglobulin E receptors (FcepsilonRI) on planar ligand-presenting surfaces.
  • We have quantified the spatiotemporal dynamics of the redistribution of immunoglobulin E-loaded receptors (IgE-FcepsilonRI) on rat basophilic leukemia-2H3 mast cells in contact with fluid and gel-phase membranes displaying ligands for immunoglobulin E, using total internal reflection fluorescence microscopy.
  • [MeSH-major] 1,2-Dipalmitoylphosphatidylcholine / metabolism. Cell Membrane / metabolism. Leukemia, Basophilic, Acute / metabolism. Leukemia, Basophilic, Acute / pathology. Phosphatidylcholines / metabolism. Receptors, IgE / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.
  • [Cites] J Cell Biol. 1994 May;125(4):795-802 [8188747.001]
  • [Cites] Traffic. 2003 May;4(5):302-12 [12713658.001]
  • [Cites] J Immunol. 1995 Oct 1;155(7):3601-9 [7561059.001]
  • [Cites] Biophys J. 1998 Sep;75(3):1553-72 [9726957.001]
  • [Cites] Nature. 1998 Sep 3;395(6697):82-6 [9738502.001]
  • [Cites] Biophys J. 1999 Feb;76(2):963-77 [9916027.001]
  • [Cites] Science. 1999 Jul 9;285(5425):221-7 [10398592.001]
  • [Cites] IEEE Trans Image Process. 2005 Sep;14(9):1237-45 [16190460.001]
  • [Cites] IEEE Trans Image Process. 2005 Sep;14(9):1372-83 [16190472.001]
  • [Cites] J Cell Biol. 2005 Nov 7;171(3):527-36 [16275755.001]
  • [Cites] Nat Immunol. 2005 Dec;6(12):1253-62 [16273097.001]
  • [Cites] Mol Cell Biol. 2006 Mar;26(5):1826-38 [16479002.001]
  • [Cites] Ann Biomed Eng. 2001 Jan;29(1):1-8 [11219503.001]
  • [Cites] Immunol Lett. 2010 Feb 16;128(2):98-104 [19900479.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5819-22 [12721367.001]
  • [Cites] J Immunol. 1980 Jun;124(6):2728-37 [7373045.001]
  • [Cites] Biophys J. 1979 Apr;26(1):115-31 [262408.001]
  • [Cites] J Biol Chem. 1982 Jun 10;257(11):6440-5 [6804467.001]
  • [Cites] J Cell Biol. 1986 Feb;102(2):541-50 [2935543.001]
  • [Cites] J Cell Biol. 1986 Jun;102(6):2185-96 [2423534.001]
  • [Cites] Prog Allergy. 1988;42:185-245 [2845426.001]
  • [Cites] J Cell Physiol. 1991 Jul;148(1):139-51 [1830592.001]
  • [Cites] J Immunol. 1992 Jan 15;148(2):524-31 [1370314.001]
  • [Cites] J Cell Biol. 1992 Feb;116(4):997-1006 [1370839.001]
  • [Cites] Biophys J. 1992 May;61(5):1402-12 [1534697.001]
  • [Cites] J Immunol. 1992 Sep 1;149(5):1477-87 [1324276.001]
  • [Cites] Biophys J. 1993 Sep;65(3):1135-46 [8241393.001]
  • [Cites] Cell Biochem Biophys. 2007;49(3):141-64 [17952641.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20296-301 [18077330.001]
  • [Cites] Immunol Rev. 2008 Feb;221:64-76 [18275475.001]
  • [Cites] Biophys J. 2008 Mar 15;94(6):2320-32 [18096627.001]
  • [Cites] PLoS Biol. 2008 Feb;6(2):e43 [18303949.001]
  • [Cites] Biophys J. 2008 Apr 15;94(8):3286-92 [18199675.001]
  • [Cites] FASEB J. 2008 Apr;22(4):1002-8 [17984179.001]
  • [Cites] Nature. 2008 Jul 24;454(7203):445-54 [18650915.001]
  • [Cites] J Cell Biol. 2008 Jul 28;182(2):367-79 [18644892.001]
  • [Cites] Nat Cell Biol. 2008 Aug;10(8):955-63 [18641640.001]
  • [Cites] Biophys J. 2008 Dec;95(11):5385-98 [18805922.001]
  • [Cites] J Microsc. 2009 Jan;233(1):84-92 [19196415.001]
  • [Cites] Langmuir. 2009 Mar 3;25(5):2986-93 [19437708.001]
  • [Cites] Blood. 2009 Dec 3;114(24):4979-88 [19805617.001]
  • [Cites] J Immunol. 2010 Feb 1;184(3):1328-38 [20042583.001]
  • [Cites] Biophys J. 1994 Apr;66(4):1231-43 [8038394.001]
  • (PMID = 20643056.001).
  • [ISSN] 1542-0086
  • [Journal-full-title] Biophysical journal
  • [ISO-abbreviation] Biophys. J.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI051575; United States / NIAID NIH HHS / AI / R01 AI051575-08
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ligands; 0 / Phosphatidylcholines; 0 / Receptors, IgE; 2644-64-6 / 1,2-Dipalmitoylphosphatidylcholine; TE895536Y5 / 1-palmitoyl-2-oleoylphosphatidylcholine
  • [Other-IDs] NLM/ PMC2905106
  •  go-up   go-down


67. Tefferi A, Elliott MA, Pardanani A: Atypical myeloproliferative disorders: diagnosis and management. Mayo Clin Proc; 2006 Apr;81(4):553-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The World Health Organization system for classification of tumors of the hematopoietic system divides myeloid disorders into acute myeloid leukemia and chronic myeloid disorders based on the presence or absence, respectively, of acute myeloid leukemia--defining morphological and cytogenetic features including the presence of 20% or more myeloblasts in either the bone marrow or the peripheral blood.
  • Classic MPD includes polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia, and chronic myeloid leukemia.
  • The current review focuses on the diagnosis and treatment of both molecularly defined and clinicopathologically assigned categories of atypical MPD: chronic myelomonocytic leukemia, juvenile myelomonocytic leukemia, chronic neutrophilic leukemia, chronic basophilic leukemia, chronic eosinophilic leukemia, idiopathic eosinophilia including hypereosinophilic syndrome, systemic mastocytosis, unclassified MPD, and eosinophilic/mast cell disorders associated with mutations of platelet-derived growth factor receptors alpha (PDGFRA) and beta (PDGFRB), FGFR1, and KIT.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16610578.001).
  • [ISSN] 0025-6196
  • [Journal-full-title] Mayo Clinic proceedings
  • [ISO-abbreviation] Mayo Clin. Proc.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 173
  •  go-up   go-down


68. Nichols MG, Barth EE, Nichols JA: Reduction in DNA synthesis during two-photon microscopy of intrinsic reduced nicotinamide adenine dinucleotide fluorescence. Photochem Photobiol; 2005 Mar-Apr;81(2):259-69
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When imaging the punctate mitochondrial fluorescence originating from NAD(P)H in a rat basophilic leukemia (RBL) cell at low laser powers, no morphological changes are evident, and photobleaching is not observed when many images are taken.
  • [MeSH-major] DNA / biosynthesis. Leukemia, Basophilic, Acute / metabolism. Microscopy, Fluorescence, Multiphoton / methods. NADP / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15647000.001).
  • [ISSN] 0031-8655
  • [Journal-full-title] Photochemistry and photobiology
  • [ISO-abbreviation] Photochem. Photobiol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / F32 CA 72225; United States / NCRR NIH HHS / RR / RR04224
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 53-59-8 / NADP; 9007-49-2 / DNA
  •  go-up   go-down


69. Tiede LM, Nichols MG: Photobleaching of reduced nicotinamide adenine dinucleotide and the development of highly fluorescent lesions in rat basophilic leukemia cells during multiphoton microscopy. Photochem Photobiol; 2006 May-Jun;82(3):656-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Photobleaching of reduced nicotinamide adenine dinucleotide and the development of highly fluorescent lesions in rat basophilic leukemia cells during multiphoton microscopy.
  • The loss of fluorescence because of multiphoton photobleaching was measured by repetitively imaging individual planes within rat basophilic leukemia cells.
  • [MeSH-major] Leukemia, Basophilic, Acute / pathology. NAD / radiation effects. Photobleaching

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16426080.001).
  • [ISSN] 0031-8655
  • [Journal-full-title] Photochemistry and photobiology
  • [ISO-abbreviation] Photochem. Photobiol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / F32 CA 72225; United States / NCRR NIH HHS / RR / RR04224
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0U46U6E8UK / NAD
  •  go-up   go-down


70. Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP: FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA. J Immunol; 2007 Mar 15;178(6):3973-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The two different alleles demonstrate significantly different FcalphaRI-mediated intracellular calcium mobilization and degranulation in rat basophilic leukemia cells and cytokine production (IL-6 and TNF-alpha) in murine macrophage P388D1 cells.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17339498.001).
  • [ISSN] 0022-1767
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / P30 AR 48311; United States / NIAMS NIH HHS / AR / R01 AR 33062; United States / NIAMS NIH HHS / AR / P30 AR048311; United States / NCRR NIH HHS / RR / M01 RR 00032; United States / NIAMS NIH HHS / AR / R01 AR033062; United States / NIAID NIH HHS / AI / N01 AI 40068; United States / NIAMS NIH HHS / AR / P01 AR 49084
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Fc(alpha) receptor; 0 / IL6 protein, human; 0 / Immunoglobulin A; 0 / Interleukin-6; 0 / Receptors, Fc; 0 / Tumor Necrosis Factor-alpha
  •  go-up   go-down


71. Torigoe C, Faeder JR, Oliver JM, Goldstein B: Kinetic proofreading of ligand-FcepsilonRI interactions may persist beyond LAT phosphorylation. J Immunol; 2007 Mar 15;178(6):3530-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Experiments in which the concentrations of two ligands with different dwell times are adjusted to equalize the level of LAT phosphorylation in rat basophilic leukemia 2H3 cells show that Erk2 phosphorylation, intracellular Ca(2+), and degranulation exhibit kinetic proofreading downstream of LAT phosphorylation.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trends Cell Biol. 2000 May;10(5):173-8 [10754559.001]
  • [Cites] Sci STKE. 2006 Jul 17;2006(344):re6 [16849649.001]
  • [Cites] J Biol Chem. 2000 Nov 10;275(45):34976-82 [10956655.001]
  • [Cites] Blood. 2001 Mar 1;97(5):1352-9 [11222380.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7289-94 [11371625.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7295-300 [11390967.001]
  • [Cites] Immunity. 2001 Jul;15(1):59-70 [11485738.001]
  • [Cites] J Cell Biol. 2001 Aug 6;154(3):645-58 [11489921.001]
  • [Cites] Nat Immunol. 2002 Aug;3(8):741-8 [12089510.001]
  • [Cites] J Cell Biol. 2002 Sep 30;158(7):1263-75 [12356870.001]
  • [Cites] Bull Math Biol. 2002 Sep;64(5):887-911 [12391861.001]
  • [Cites] J Immunol. 2003 Mar 1;170(5):2680-7 [12594297.001]
  • [Cites] J Immunol. 2003 Apr 1;170(7):3769-81 [12646643.001]
  • [Cites] J Exp Med. 2003 Jun 2;197(11):1453-65 [12782712.001]
  • [Cites] J Exp Med. 2003 Sep 1;198(5):831-43 [12953098.001]
  • [Cites] Nat Rev Immunol. 2004 Jun;4(6):445-56 [15173833.001]
  • [Cites] Mol Immunol. 2004 Jul;41(8):817-29 [15234561.001]
  • [Cites] Nat Rev Immunol. 2004 Aug;4(8):603-16 [15286727.001]
  • [Cites] J Immunol. 1980 Jun;124(6):2728-37 [7373045.001]
  • [Cites] Eur J Immunol. 1981 Apr;11(4):317-23 [6166481.001]
  • [Cites] J Immunol. 1992 Oct 1;149(7):2428-36 [1388191.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 May 23;92(11):5042-6 [7761445.001]
  • [Cites] Biochemistry. 1996 Apr 23;35(16):5327-32 [8611520.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1372-7 [9037060.001]
  • [Cites] Biophys J. 1997 May;72(5):2014-31 [9129805.001]
  • [Cites] J Biol Chem. 1997 May 30;272(22):14067-73 [9162030.001]
  • [Cites] Science. 1998 Jul 24;281(5376):568-72 [9677201.001]
  • [Cites] Trends Immunol. 2005 Mar;26(3):119-22 [15745852.001]
  • [Cites] Biochim Biophys Acta. 2005 Dec 30;1746(3):252-9 [16054713.001]
  • [Cites] Nat Rev Immunol. 2006 Jan;6(1):67-78 [16493428.001]
  • [Cites] Nat Rev Immunol. 2006 Mar;6(3):218-30 [16470226.001]
  • [Cites] J Allergy Clin Immunol. 2006 Jun;117(6):1214-25; quiz 1226 [16750977.001]
  • [Cites] Immunity. 2000 May;12(5):525-35 [10843385.001]
  • (PMID = 17339448.001).
  • [ISSN] 0022-1767
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R37 GM 35556; United States / NIBIB NIH HHS / EB / EB005365-03; United States / NIGMS NIH HHS / GM / F32 GM065794; United States / NIGMS NIH HHS / GM / P20 GM 065794; United States / NIGMS NIH HHS / GM / R37 GM035556; United States / NIBIB NIH HHS / EB / R21 EB005365-03; United States / NIGMS NIH HHS / GM / R01 GM 49814; United States / NIGMS NIH HHS / GM / R01 GM049814
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / Lat protein, rat; 0 / Ligands; 0 / Membrane Proteins; 0 / Phosphoproteins; 0 / Receptors, IgE; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1
  • [Other-IDs] NLM/ NIHMS60574; NLM/ PMC2593628
  •  go-up   go-down


72. Leung WH, Bolland S: The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J Immunol; 2007 Jul 1;179(1):95-102
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Coimmunoprecipitation experiments in rat basophilic leukemia (RBL 2H3) cells show that SHIP-2 interacts with the FcepsilonRI beta-chain, Gab2 and Lyn and that unlike SHIP-1, it does not associate with SHC in mast cells.


73. Matsui T, Nunomura S, Shimokawa T, Yoshimaru T, Ra C: Functionality of the IgA Fc receptor (FcalphaR, CD89) is down-regulated by extensive engagement of FcepsilonRI. Clin Immunol; 2008 Oct;129(1):155-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Transfected rat basophilic leukemia cell line (RBL-2H3) co-expressing FcepsilonRI and FcalphaR was analyzed for effects of simultaneous receptor engagement by their specific antibodies on degranulation and signaling.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18700185.001).
  • [ISSN] 1521-7035
  • [Journal-full-title] Clinical immunology (Orlando, Fla.)
  • [ISO-abbreviation] Clin. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD; 0 / Bicyclo Compounds, Heterocyclic; 0 / Fc(alpha) receptor; 0 / Receptors, Fc; 0 / Receptors, IgE; 0 / Thiazolidines; 76343-94-7 / latrunculin B; EC 3.1.3.- / Phosphoric Monoester Hydrolases; EC 3.1.3.56 / inositol-polyphosphate 5-phosphatase
  •  go-up   go-down


74. Yamada P, Iijima R, Han J, Shigemori H, Yokota S, Isoda H: Inhibitory effect of acteoside isolated from Cistanche tubulosa on chemical mediator release and inflammatory cytokine production by RBL-2H3 and KU812 cells. Planta Med; 2010 Oct;76(14):1512-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Wight on the basophilic cell-mediated allergic reaction.
  • The effect of acteoside on β-hexosaminidase release and intracellular [Ca (2+)] I level from rat basophilic leukemia (RBL-2H3) cells was determined.
  • Also, ELISA was used to determine the level of histamine, tumor necrosis factor (TNF)- α, and interleukin (IL)-4 on human basophilic (KU812) cells.
  • The effect of acteoside on basophilic cell viability was determined using the 3-[4,5-dimethylthiazolyl]-2,5-diphenyltetrazolium bromide (MTT) assay.
  • Our findings provide evidence that acteoside inhibits basophilic cell-derived immediate-type and delayed-type allergic reactions.
  • This is the first report describing antiallergic activity of acteoside extracted from CISTANCHE TUBULOSA on basophilic cells.

  • National BioResource Project. culture/stock collections - NBRP resources .
  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • Hazardous Substances Data Bank. HISTAMINE .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 20354949.001).
  • [ISSN] 1439-0221
  • [Journal-full-title] Planta medica
  • [ISO-abbreviation] Planta Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Catechols; 0 / Glucosides; 0 / Glycosides; 0 / IL4 protein, human; 0 / Phenols; 0 / Tumor Necrosis Factor-alpha; 0 / cistanoside A; 207137-56-2 / Interleukin-4; 37H9VM9WZL / Calcimycin; 61276-17-3 / acteoside; 820484N8I3 / Histamine; 82854-37-3 / echinacoside; EC 3.2.1.52 / beta-N-Acetylhexosaminidases; NI40JAQ945 / Tetradecanoylphorbol Acetate; SY7Q814VUP / Calcium
  •  go-up   go-down


75. Rettig JR, Folch A: Large-scale single-cell trapping and imaging using microwell arrays. Anal Chem; 2005 Sep 1;77(17):5628-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have characterized microwell occupancy by cells for a range of microwell dimensions and seeding parameters and optimized it for fibroblasts (as a model of adherent cell) and rat basophilic leukemia cells (as a model of nonadherent cell).

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16131075.001).
  • [ISSN] 0003-2700
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Grant] United States / NIDCD NIH HHS / DC / R21DC006465
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


76. Mitsutake S, Igarashi Y: Transbilayer movement of ceramide in the plasma membrane of live cells. Biochem Biophys Res Commun; 2007 Aug 3;359(3):622-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To produce Cer on the extracellular leaflet of the PM, bacterial sphingomyelinase (SMase) was added to rat basophilic leukemia cells.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17553461.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ceramides; 0 / Membrane Transport Proteins; 0 / Phosphates; 97C5T2UQ7J / Cholesterol; EC 3.1.4.12 / Sphingomyelin Phosphodiesterase
  •  go-up   go-down


77. Edwards BS, Young SM, Ivnitsky-Steele I, Ye RD, Prossnitz ER, Sklar LA: High-content screening: flow cytometry analysis. Methods Mol Biol; 2009;486:151-65
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-content screening: flow cytometry analysis.
  • The HyperCyt high-throughput (HT) flow cytometry sampling platform uses a peristaltic pump, in combination with an autosampler, and a novel approach to data collection, to circumvent time-delay bottlenecks of conventional flow cytometry.
  • This approach also dramatically reduces the amount of sample aspirated for each analysis, typically requiring ~2 microL per sample while making quantitative fluorescence measurements of 40 or more samples per minute with thousands to tens of thousands of cells in each sample.
  • Here, we describe a simple robust screening assay that exploits the high-content measurement capabilities of the flow cytometer to simicroltaneously probe the binding of test compounds to two different receptors in a common assay volume, a duplex assay format.
  • The ability of the flow cytometer to distinguish cell-bound from free fluorophore is also exploited to eliminate wash steps during assay setup.
  • HT flow cytometry with this assay has allowed efficient screening of tens of thousands of small molecules from the NIH Small-Molecule Repository to identify selective ligands for two related G-protein-coupled receptors, the formylpeptide receptor and formylpeptide receptor-like 1.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19347622.001).
  • [ISSN] 1064-3745
  • [Journal-full-title] Methods in molecular biology (Clifton, N.J.)
  • [ISO-abbreviation] Methods Mol. Biol.
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / R03 MH076381; United States / NIMH NIH HHS / MH / U54 MH074425; United States / NIMH NIH HHS / MH / R03 MH076381-01; United States / NIMH NIH HHS / MH / U54 MH074425-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / FPR2 protein, human; 0 / Ligands; 0 / Receptors, Formyl Peptide; 0 / Receptors, Lipoxin
  • [Other-IDs] NLM/ NIHMS650482; NLM/ PMC4476789
  •  go-up   go-down


78. Grégoire MJ, Latger-Cannard V, Staal A, Bologna S, Leotard B, Rault JP, Béry-Dexheimer M, Jonveaux P: Identification of an acute basophilic leukaemia carrying a rare e6a2 BCR-ABL transcript. Acta Haematol; 2006;116(3):216-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of an acute basophilic leukaemia carrying a rare e6a2 BCR-ABL transcript.
  • [MeSH-major] Fusion Proteins, bcr-abl / genetics. Leukemia, Basophilic, Acute / genetics

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17016044.001).
  • [ISSN] 0001-5792
  • [Journal-full-title] Acta haematologica
  • [ISO-abbreviation] Acta Haematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] EC 2.7.10.2 / Fusion Proteins, bcr-abl
  •  go-up   go-down


79. Reese G, Schicktanz S, Lauer I, Randow S, Lüttkopf D, Vogel L, Lehrer SB, Vieths S: Structural, immunological and functional properties of natural recombinant Pen a 1, the major allergen of Brown Shrimp, Penaeus aztecus. Clin Exp Allergy; 2006 Apr;36(4):517-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mediator release experiments using both wild-type and humanized rat basophilic leukaemia 30/25 cells showed that rPen a 1 and nPen a 1 induced a similar level of mast cell activation.
  • [MeSH-minor] Amino Acid Sequence. Animals. Base Sequence. Basophils / immunology. Cells, Cultured. Circular Dichroism / methods. DNA, Circular / chemistry. Female. Humans. Hypersensitivity / immunology. Immunoglobulin E / immunology. Leukemia / immunology. Mice. Mice, Inbred C3H. Models, Biological. Protein Conformation. Radioallergosorbent Test / methods. Rats. Transfection / methods. Tropomyosin / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16630158.001).
  • [ISSN] 0954-7894
  • [Journal-full-title] Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • [ISO-abbreviation] Clin. Exp. Allergy
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Allergens; 0 / DNA, Circular; 0 / Pen a 1 allergen, Penaeus aztecus; 0 / Recombinant Proteins; 0 / Tropomyosin; 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


80. Stratmann H, Schwan C, Orth JH, Schmidt G, Aktories K: Pleiotropic role of Rac in mast cell activation revealed by a cell permeable Bordetella dermonecrotic fusion toxin. Cell Signal; 2010 Jul;22(7):1124-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To activate the GTPase Rac in rat basophilic leukemia (RBL) cells and mouse bone marrow-derived mast cells (BMMC) a TAT fusion toxin of Bordetella dermonecrotic toxin (DNT-TAT) was constructed.

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20211724.001).
  • [ISSN] 1873-3913
  • [Journal-full-title] Cellular signalling
  • [ISO-abbreviation] Cell. Signal.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Peptides; 0 / Recombinant Fusion Proteins; 0 / Virulence Factors, Bordetella; 0 / dermonecrotic toxin, Bordetella; EC 2.3.2.13 / Transglutaminases; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 3.6.5.2 / rac1 GTP-Binding Protein; EC 3.6.5.2 / rho GTP-Binding Proteins; SY7Q814VUP / Calcium
  •  go-up   go-down


81. Wagner S, Radauer C, Bublin M, Hoffmann-Sommergruber K, Kopp T, Greisenegger EK, Vogel L, Vieths S, Scheiner O, Breiteneder H: Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. J Allergy Clin Immunol; 2008 Jan;121(1):246-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Isoform structures were compared and related to IgE-binding inhibitory capacities and induction of mediator release in human Fcvarepsilon receptor transformed rat basophilic leukemia cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17889932.001).
  • [ISSN] 1097-6825
  • [Journal-full-title] The Journal of allergy and clinical immunology
  • [ISO-abbreviation] J. Allergy Clin. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Allergens; 0 / Antibodies, Blocking; 0 / Antigens, Plant; 0 / Immunoglobulin G; 0 / Plant Proteins; 0 / Protein Isoforms; 126161-14-6 / Bet v 1 allergen, Betula; 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


82. Lim H, Son KH, Chang HW, Bae K, Kang SS, Kim HP: Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from Cirsium chanroenicum. Biol Pharm Bull; 2008 Nov;31(11):2063-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to identify the active anti-inflammatory ingredient(s) in Cirsium chanroenicum (Compositae), its methanol extract and several solvent fractions were prepared; the methanol extract and the ethylacetate fraction inhibited cyclooxygenase-2 (COX-2)-mediated prostaglandin E2 (PGE2) and 5-lipoxygenase (5-LOX)-mediated leukotriene (LT) production in lipopolysaccharide-treated RAW 264.7 cells and A23187-treated rat basophilic leukemia (RBL-1) cells, respectively.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981574.001).
  • [ISSN] 0918-6158
  • [Journal-full-title] Biological & pharmaceutical bulletin
  • [ISO-abbreviation] Biol. Pharm. Bull.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Chromones; 0 / Leukotrienes; 0 / NF-kappa B; 0 / pectolinarigenin; 28978-02-1 / pectolinarin; EC 1.13.11.34 / Arachidonate 5-Lipoxygenase; EC 1.14.99.1 / Cyclooxygenase 2; K7Q1JQR04M / Dinoprostone
  •  go-up   go-down


83. Huelsenbeck SC, Klose I, Reichenbach M, Huelsenbeck J, Genth H: Distinct kinetics of (H/K/N)Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin. FEBS Lett; 2009 Oct 6;583(19):3133-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Alternative Ras antibodies including the K-Ras(Mab F234) antibody or the v-H-Ras(Mab Y13-159) antibody recognize Ras proteins regardless of glucosylation. (H/K)Ras are further shown to be more efficaciously glucosylated by TcsL than Rac1 in rat basophilic leukemia cells as well as in a cell-free system.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19744486.001).
  • [ISSN] 1873-3468
  • [Journal-full-title] FEBS letters
  • [ISO-abbreviation] FEBS Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies; 0 / Bacterial Toxins; 0 / lethal toxin LT, Clostridium sordellii; EC 3.6.5.2 / rac1 GTP-Binding Protein; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


84. Wimazal F, Baumgartner C, Sonneck K, Zauner C, Geissler P, Schur S, Samorapoompichit P, Müllauer L, Födinger M, Agis H, Sperr WR, Valent P: Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression. Eur J Clin Invest; 2008 Jun;38(6):447-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
  • BACKGROUND: Basophilic crisis and eosinophilia are well recognized features of advanced chronic myeloid leukaemia.
  • DESIGN: We examined the long-term follow-up of 322 patients with de novo myelodysplastic syndromes (MDS) to define the frequency of basophilic, eosinophilic and mixed lineage (basophilic and eosinophilic) transformation.
  • In this patient, who initially suffered from chronic myelomonocytic leukaemia, basophils increased to 48% and eosinophils up to 31% at the time of progression.
  • Myelomastocytic transformation/myelomastocytic leukaemia and primary mast cell disease were excluded by histology, KIT mutation analysis, electron microscopy and immunophenotyping.
  • CONCLUSIONS: Mixed basophil/eosinophil crisis may develop in patients with MDS but is an extremely rare event.
  • [MeSH-major] Basophils / immunology. Eosinophils / immunology. Leukemia, Myelomonocytic, Chronic / immunology

  • Hazardous Substances Data Bank. HYDROXYUREA .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18445043.001).
  • [ISSN] 1365-2362
  • [Journal-full-title] European journal of clinical investigation
  • [ISO-abbreviation] Eur. J. Clin. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Receptors, IgE; X6Q56QN5QC / Hydroxyurea
  •  go-up   go-down


85. Smetana K, Klamová H, Jirásková I, Mikulenková D: A short cytochemical note on the nucleolar and cytoplasmic RNA concentration in differentiating cells represented by human erythroblasts. Acta Histochem; 2010 Jul;112(4):407-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The bone marrow of patients suffering from the chronic phase of chronic myeloid leukaemia without a large increase in the granulocyte to erythroid ratio provided erythroblasts for computer-assisted image density measurements of RNA in nucleoli and cytoplasm at the single cell level.
  • In contrast, the nucleolar size significantly decreased even during the early stages of erythroid development (basophilic erythroblasts).
  • [MeSH-minor] Cells, Cultured. Humans. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier GmbH. All rights reserved.
  • (PMID = 19386355.001).
  • [ISSN] 1618-0372
  • [Journal-full-title] Acta histochemica
  • [ISO-abbreviation] Acta Histochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 63231-63-0 / RNA
  •  go-up   go-down


86. Itoh T, Ninomiya M, Nozawa Y, Koketsu M: Chalcone glycosides isolated from aerial parts of Brassica rapa L. 'hidabeni' suppress antigen-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells. Bioorg Med Chem; 2010 Oct 1;18(19):7052-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chalcone glycosides isolated from aerial parts of Brassica rapa L. 'hidabeni' suppress antigen-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells.
  • We isolated three chalcone glycosides along with other glycoside constituents from the aerial parts of Brassica rapa L. 'hidabeni' and examined the effects of these compounds on the antigen-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20801664.001).
  • [ISSN] 1464-3391
  • [Journal-full-title] Bioorganic & medicinal chemistry
  • [ISO-abbreviation] Bioorg. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens; 0 / Biphenyl Compounds; 0 / Chalcones; 0 / Free Radical Scavengers; 0 / Glycosides; 0 / Picrates; 0 / Plant Extracts; 0 / Reactive Oxygen Species; 1898-66-4 / 2,2-diphenyl-1-picrylhydrazyl; EC 1.6.3.1 / NADPH Oxidase
  •  go-up   go-down


87. Parusel I, Kahl S, Braasch F, Glowacki G, Halverson GR, Reid ME, Schawalder A, Ortolan E, Funaro A, Malavasi F, Hardie D, Halder S, Buckley CD, Haag F, Koch-Nolte F: A panel of monoclonal antibodies recognizing GPI-anchored ADP-ribosyltransferase ART4, the carrier of the Dombrock blood group antigens. Cell Immunol; 2005 Jul-Aug;236(1-2):59-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mAbs reacted weakly also with human umbilical vein endothelial cells and the basophilic leukemia KU-812.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16168396.001).
  • [ISSN] 0008-8749
  • [Journal-full-title] Cellular immunology
  • [ISO-abbreviation] Cell. Immunol.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / HL54459
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Cell Cycle Proteins; 0 / GML protein, human; 0 / GPI-Linked Proteins; 0 / Membrane Proteins; 0 / Neoplasm Proteins; EC 2.4.2.- / ADP Ribose Transferases; EC 2.4.2.31 / ART4 protein, human
  •  go-up   go-down


88. Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wang JM: Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst; 2005 Jun 1;97(11):823-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Endogenous FPR agonist activity released by necrotic tumor cells was assessed by measuring FPR activation in an FPR-transfected basophil leukemia cell line and live U-87 cells.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15928303.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Small Interfering; 0 / Receptors, Formyl Peptide; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


89. Brock TG: Capturing proteins that bind polyunsaturated fatty acids: demonstration using arachidonic acid and eicosanoids. Lipids; 2008 Feb;43(2):161-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Animals. Cell Line, Tumor. Electrophoresis, Gel, Two-Dimensional. Hydroxyeicosatetraenoic Acids / chemistry. Hydroxyeicosatetraenoic Acids / metabolism. Leukemia, Basophilic, Acute / metabolism. Rats

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell Signal. 1996 Aug;8(5):397-402 [8911691.001]
  • [Cites] Lancet. 1998 Jan 24;351(9098):233-41 [9457092.001]
  • [Cites] Eur J Pharmacol. 1994 May 17;267(3):275-80 [8088366.001]
  • [Cites] Arch Biochem Biophys. 2000 Jul 1;379(1):119-26 [10864449.001]
  • [Cites] J Immunol. 1991 Jul 1;147(1):231-6 [1646842.001]
  • [Cites] Circulation. 2002 Apr 23;105(16):1897-903 [11997274.001]
  • [Cites] Mol Carcinog. 2006 Sep;45(9):657-66 [16649253.001]
  • [Cites] Biochemistry. 1999 Sep 21;38(38):12229-39 [10493790.001]
  • [Cites] Biochem J. 2006 Feb 15;394(Pt 1):185-95 [16268779.001]
  • [Cites] J Biol Chem. 1999 May 14;274(20):13900-7 [10318799.001]
  • [Cites] Science. 2001 Jun 15;292(5524):2083-6 [11408659.001]
  • [Cites] Biochem J. 2007 Aug 1;405(3):379-95 [17623009.001]
  • [Cites] Mol Biol Cell. 1993 Mar;4(3):261-9 [8387355.001]
  • [Cites] J Biol Chem. 1993 Dec 15;268(35):26206-11 [8253741.001]
  • [Cites] J Am Soc Nephrol. 2006 Jan;17(1):89-98 [16291835.001]
  • [Cites] Int J Biochem Cell Biol. 2001 Sep;33(9):865-76 [11461829.001]
  • [Cites] Am Heart J. 1991 Dec;122(6):1588-92 [1957753.001]
  • [Cites] Biochemistry. 2007 Mar 13;46(10):2707-18 [17297918.001]
  • [Cites] J Biol Chem. 1993 Jul 15;268(20):14708-14 [8392058.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4182-7 [9108126.001]
  • [Cites] J Biol Chem. 1981 Dec 25;256(24):12640-3 [6273400.001]
  • [Cites] Biochem J. 1995 Feb 1;305 ( Pt 3):859-64 [7848286.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Dec 17;325(3):1060-5 [15541396.001]
  • [Cites] FEBS Lett. 1988 Nov 21;240(1-2):163-6 [3191990.001]
  • [Cites] Adv Neurol. 1990;52:105-8 [2118711.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11280-5 [11005842.001]
  • [Cites] Pflugers Arch. 1997 Jan;433(3):245-53 [9064639.001]
  • [Cites] J Biol Chem. 1997 Sep 5;272(36):22464-71 [9278397.001]
  • [Cites] Am J Respir Cell Mol Biol. 1995 Mar;12(3):260-7 [7873191.001]
  • [Cites] Anal Biochem. 1997 Jul 15;250(1):119-22 [9234906.001]
  • [Cites] Nature. 1997 Jun 5;387(6633):620-4 [9177352.001]
  • [Cites] Eur J Clin Nutr. 1998 Oct;52(10):749-53 [9805223.001]
  • [Cites] Cell Mol Life Sci. 2007 Oct;64(19-20):2657-70 [17639273.001]
  • [Cites] Brain Res. 1988 Sep 6;459(2):344-50 [2846118.001]
  • [Cites] Chem Res Toxicol. 2003 Apr;16(4):551-61 [12703973.001]
  • [Cites] J Biol Chem. 1993 Apr 25;268(12):8624-31 [8386165.001]
  • [Cites] Biochim Biophys Acta. 1974 Apr 26;348(1):76-85 [4838223.001]
  • [Cites] N Engl J Med. 1989 Jul 20;321(3):129-35 [2664509.001]
  • [Cites] J Biol Chem. 1997 Apr 4;272(14):9371-7 [9083074.001]
  • [Cites] J Pharmacol Sci. 2003 Aug;92(4):308-16 [12939515.001]
  • [Cites] Toxicol Sci. 2003 Aug;74(2):361-8 [12773768.001]
  • [Cites] J Biol Chem. 2001 May 11;276(19):15575-80 [11278949.001]
  • [Cites] Biochem J. 2005 Jan 1;385(Pt 1):45-56 [15383005.001]
  • [Cites] J Am Coll Nutr. 1999 Oct;18(5):487-9 [10511332.001]
  • [Cites] J Exp Med. 2000 Aug 7;192(3):421-32 [10934230.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9886-90 [7937911.001]
  • [Cites] Eur Heart J. 1989 Jun;10(6):558-67 [2547617.001]
  • (PMID = 18084788.001).
  • [ISSN] 0024-4201
  • [Journal-full-title] Lipids
  • [ISO-abbreviation] Lipids
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI43574
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Eicosanoids; 0 / Fatty Acid-Binding Proteins; 0 / Fatty Acids, Unsaturated; 0 / Hydroxyeicosatetraenoic Acids; 27YG812J1I / Arachidonic Acid
  •  go-up   go-down


90. Trinh HT, Chae SJ, Joh EH, Son KH, Jeon SJ, Kim DH: Tanshinones isolated from the rhizome of Salvia miltiorrhiza inhibit passive cutaneous anaphylaxis reaction in mice. J Ethnopharmacol; 2010 Oct 28;132(1):344-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Protein expression of IL-4 and TNF-α in rat basophilic leukemia (RBL)-2H3 cells was performed by enzyme-linked immunosorbent assay and NF-κB and c-jun (AP-1) activation assayed by immunoblot.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20732401.001).
  • [ISSN] 1872-7573
  • [Journal-full-title] Journal of ethnopharmacology
  • [ISO-abbreviation] J Ethnopharmacol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Diterpenes, Abietane; 0 / Drugs, Chinese Herbal; 0 / NF-kappa B; 0 / Phenanthrenes; 0 / Proto-Oncogene Proteins c-jun; 0 / Salvia extract; 0 / Tumor Necrosis Factor-alpha; 03UUH3J385 / tanshinone; 207137-56-2 / Interleukin-4
  •  go-up   go-down


91. Chikamatsu S, Furuno T, Kinoshita Y, Inoh Y, Hirashima N, Teshima R, Nakanishi M: Effects of Cot expression on the nuclear translocation of NF-kappaB in RBL-2H3 cells. Mol Immunol; 2007 Mar;44(7):1490-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we have shown that Cot kinase activity is intimately involved in the high affinity receptor for IgE (FcvarepsilonRI)-mediated nuclear translocation of NF-kappaB1 independent of NF-kappaB-inducing kinase (NIK) in rat basophilic leukemia (RBL-2H3) cells.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17049604.001).
  • [ISSN] 0161-5890
  • [Journal-full-title] Molecular immunology
  • [ISO-abbreviation] Mol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Luminescent Proteins; 0 / NF-kappa B; 0 / Proto-Oncogene Proteins; 0 / Receptors, IgE; 0 / red fluorescent protein; 147336-22-9 / Green Fluorescent Proteins; EC 2.7.11.25 / MAP Kinase Kinase Kinases; EC 2.7.11.25 / Map3k8 protein, rat
  •  go-up   go-down


92. Lee JY, Jang YW, Kang HS, Moon H, Sim SS, Kim CJ: Anti-inflammatory action of phenolic compounds from Gastrodia elata root. Arch Pharm Res; 2006 Oct;29(10):849-58
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the anti-inflammatory and anti-oxidant activity of these compounds, their effects on carrageenan-induced paw edema, arachidonic acid (AA)-induced ear edema and analgesic activity in acetic acid (HAc)-induced writhing response were carried out in vivo; cyclooxygenase (COX) activity, reactive oxygen species (ROS) generation in rat basophilic leukemia (RBL 2H3) cells and 1,1-diphenyl-2-picryl-hydroazyl (DPPH) scavenging activity were determined in vitro.

  • Hazardous Substances Data Bank. ACETIC ACID .
  • Hazardous Substances Data Bank. METHANOL .
  • Hazardous Substances Data Bank. CARRAGEENAN GUM .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17121179.001).
  • [ISSN] 0253-6269
  • [Journal-full-title] Archives of pharmacal research
  • [ISO-abbreviation] Arch. Pharm. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Benzyl Compounds; 0 / Cyclooxygenase Inhibitors; 0 / Phenols; 0 / Plant Extracts; 0 / Reactive Oxygen Species; 27YG812J1I / Arachidonic Acid; 9000-07-1 / Carrageenan; EC 1.14.99.1 / Prostaglandin-Endoperoxide Synthases; Q40Q9N063P / Acetic Acid; Y4S76JWI15 / Methanol
  •  go-up   go-down


93. Sakai S, Sugawara T, Matsubara K, Hirata T: Inhibitory effect of carotenoids on the degranulation of mast cells via suppression of antigen-induced aggregation of high affinity IgE receptors. J Biol Chem; 2009 Oct 9;284(41):28172-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fucoxanthin, astaxanthin, zeaxanthin, and beta-carotene significantly inhibited the antigen-induced release of beta-hexosaminidase in rat basophilic leukemia 2H3 cells and mouse bone marrow-derived mast cells.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Rev Immunol. 2006 Mar;6(3):218-30 [16470226.001]
  • [Cites] Biosci Biotechnol Biochem. 2007 Apr;71(4):1069-72 [17420600.001]
  • [Cites] Blood. 2000 Mar 1;95(5):1752-7 [10688834.001]
  • [Cites] J Histochem Cytochem. 2000 Dec;48(12):1705-16 [11101638.001]
  • [Cites] Spectrochim Acta A Mol Biomol Spectrosc. 2000 Dec;56(14):2799-809 [11145347.001]
  • [Cites] J Biochem. 2001 Jun;129(6):861-8 [11388899.001]
  • [Cites] J Nutr. 2001 Nov;131(11):2921-7 [11694619.001]
  • [Cites] Neurochem Res. 2001 Oct;26(10):1139-44 [11700956.001]
  • [Cites] Mol Cell Biol. 2001 Dec;21(24):8318-28 [11713268.001]
  • [Cites] J Nutr. 2001 Dec;131(12):3303-6 [11739884.001]
  • [Cites] J Nutr. 2002 May;132(5):946-51 [11983819.001]
  • [Cites] Mol Cell Biol. 2002 Jun;22(12):3970-80 [12024011.001]
  • [Cites] Nat Immunol. 2002 Aug;3(8):741-8 [12089510.001]
  • [Cites] Mol Immunol. 2002 Sep;38(16-18):1247-52 [12217391.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2694-701 [12766075.001]
  • [Cites] Mol Cells. 2003 Aug 31;16(1):97-105 [14503852.001]
  • [Cites] J Immunol. 2004 Apr 1;172(7):4486-92 [15034065.001]
  • [Cites] Blood. 2004 Jul 1;104(1):207-14 [15010370.001]
  • [Cites] Biol Pharm Bull. 2004 Jul;27(7):978-84 [15256726.001]
  • [Cites] Biophys J. 1984 Jun;45(6):1203-9 [6743750.001]
  • [Cites] J Immunol. 1989 May 15;142(10):3440-6 [2785556.001]
  • [Cites] J Immunol. 1990 Sep 1;145(5):1463-8 [2200824.001]
  • [Cites] J Biol Chem. 1993 Feb 5;268(4):2280-3 [8381401.001]
  • [Cites] Biochem Biophys Res Commun. 1996 Jun 14;223(2):245-9 [8670267.001]
  • [Cites] J Biol Chem. 1997 Feb 14;272(7):4276-80 [9020144.001]
  • [Cites] Nature. 1997 Jun 5;387(6633):569-72 [9177342.001]
  • [Cites] J Cell Sci. 1998 Aug;111 ( Pt 16):2385-96 [9683633.001]
  • [Cites] Physiol Rev. 1999 Oct;79(4):1089-125 [10508230.001]
  • [Cites] J Allergy Clin Immunol. 2004 Nov;114(5):1085-92 [15536414.001]
  • [Cites] Int Arch Allergy Immunol. 2005 Apr;136(4):311-9 [15722642.001]
  • [Cites] Int Immunol. 2005 Sep;17(9):1249-55 [16103029.001]
  • [Cites] Exp Mol Med. 2005 Aug 31;37(4):323-34 [16155409.001]
  • [Cites] Exp Eye Res. 2005 Oct;81(4):422-8 [15950219.001]
  • [Cites] J Immunol. 2005 Dec 1;175(11):7602-10 [16301670.001]
  • [Cites] J Biol Chem. 2005 Dec 2;280(48):40261-70 [16176929.001]
  • [Cites] Biochim Biophys Acta. 2005 Dec 30;1746(3):252-9 [16054713.001]
  • [Cites] Acta Biochim Pol. 2006;53(3):475-84 [16964324.001]
  • [Cites] J Agric Food Chem. 2006 Dec 27;54(26):9805-10 [17177505.001]
  • [Cites] Free Radic Biol Med. 2006 May 15;40(10):1820-6 [16678020.001]
  • (PMID = 19700409.001).
  • [ISSN] 1083-351X
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens; 0 / Monoterpenes; 0 / Receptors, IgE; 36-88-4 / Carotenoids; EC 3.2.1.52 / beta-N-Acetylhexosaminidases
  • [Other-IDs] NLM/ PMC2788868
  •  go-up   go-down


94. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M: Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res; 2008 Nov 21;103(11):1289-99
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using a maneuver that amplifies currents in divalent-free bath solutions, we show that EC CRAC has similar characteristics to that recorded from rat basophilic leukemia cells, namely a similar time course of activation, sensitivity to 2-aminoethoxydiphenyl borate, and low concentrations of lanthanides, and large Na(+) currents displaying the typical depotentiation.
  • Ectopic expression of Stim1 in ECs increased their I(CRAC) to a size comparable to that in rat basophilic leukemia cells.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Cell Biol. 2001 Feb;3(2):121-7 [11175743.001]
  • [Cites] Nature. 2006 May 11;441(7090):179-85 [16582901.001]
  • [Cites] FASEB J. 2001 Aug;15(10):1727-38 [11481220.001]
  • [Cites] J Exp Med. 2002 Mar 18;195(6):673-81 [11901194.001]
  • [Cites] J Gen Physiol. 2002 May;119(5):487-507 [11981025.001]
  • [Cites] J Biol Chem. 2002 Jun 14;277(24):21617-23 [11943785.001]
  • [Cites] Circ Res. 2002 Jul 12;91(1):70-6 [12114324.001]
  • [Cites] Cell Calcium. 2002 Nov-Dec;32(5-6):379-91 [12543097.001]
  • [Cites] J Biol Chem. 2003 Aug 29;278(35):33492-500 [12766172.001]
  • [Cites] J Biol Chem. 2004 May 14;279(20):20941-9 [15016832.001]
  • [Cites] Cell Calcium. 1986 Feb;7(1):1-12 [2420465.001]
  • [Cites] Nature. 1992 Jan 23;355(6358):353-6 [1309940.001]
  • [Cites] J Physiol. 1993 Jun;465:359-86 [8229840.001]
  • [Cites] Am J Physiol. 1994 Oct;267(4 Pt 1):C920-5 [7943286.001]
  • [Cites] Am J Physiol. 1995 Jan;268(1 Pt 2):H138-46 [7530915.001]
  • [Cites] Cell Calcium. 1994 Nov;16(5):367-76 [7859251.001]
  • [Cites] Science. 2006 May 26;312(5777):1220-3 [16645049.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9357-62 [16751269.001]
  • [Cites] Pflugers Arch. 1999 Oct;438(5):612-20 [10555557.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14955-60 [10611319.001]
  • [Cites] Biochim Biophys Acta. 2006 Nov;1763(11):1147-60 [17034882.001]
  • [Cites] J Biol Chem. 2007 Jun 15;282(24):17548-56 [17452328.001]
  • [Cites] Cell Calcium. 2007 Aug;42(2):103-10 [17349691.001]
  • [Cites] Cell Calcium. 2007 Aug;42(2):133-44 [17482674.001]
  • [Cites] Cell Calcium. 2007 Aug;42(2):163-72 [17499354.001]
  • [Cites] Pflugers Arch. 2007 Dec;455(3):465-77 [17647013.001]
  • [Cites] Nat Immunol. 2008 Jan;9(1):89-96 [18059270.001]
  • [Cites] J Physiol. 2008 Jul 1;586(13):3061-73 [18403424.001]
  • [Cites] Channels (Austin). 2007 Jul-Aug;1(4):246-52 [18711860.001]
  • [Cites] Pflugers Arch. 2008 Nov;457(2):405-15 [18536932.001]
  • [Cites] Pflugers Arch. 2008 Nov;457(2):377-87 [18546016.001]
  • [Cites] Pflugers Arch. 1998 Jun;436(1):69-74 [9560448.001]
  • [Cites] J Biol Chem. 2001 Jun 22;276(25):22614-20 [11309397.001]
  • [Cites] J Gen Physiol. 1995 Feb;105(2):209-26 [7760017.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Dec 18;241(2):471-5 [9425294.001]
  • [Cites] Am J Physiol. 1998 Sep;275(3 Pt 1):L574-82 [9728053.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1303-13 [15347566.001]
  • [Cites] Physiol Rev. 2005 Apr;85(2):757-810 [15788710.001]
  • [Cites] Circ Res. 2005 Apr 29;96(8):856-63 [15790951.001]
  • [Cites] J Cell Biol. 2005 May 9;169(3):435-45 [15866891.001]
  • [Cites] Circ Res. 2005 Jun 24;96(12):1282-90 [15920022.001]
  • [Cites] Curr Biol. 2005 Jul 12;15(13):1235-41 [16005298.001]
  • [Cites] Circ Res. 2005 Nov 25;97(11):1164-72 [16254212.001]
  • [CommentIn] Circ Res. 2009 Jan 30;104(2):e22-3 [19179662.001]
  • (PMID = 18845811.001).
  • [ISSN] 1524-4571
  • [Journal-full-title] Circulation research
  • [ISO-abbreviation] Circ. Res.
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / K22ES014729; United States / NIEHS NIH HHS / ES / ES014729-02; United States / NIEHS NIH HHS / ES / ES014729-01; United States / NIEHS NIH HHS / ES / K22 ES014729; United States / NIEHS NIH HHS / ES / K22 ES014729-02; United States / NIEHS NIH HHS / ES / K22 ES014729-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium Channels; 0 / DNA Primers; 0 / Membrane Glycoproteins; 0 / Membrane Proteins; 0 / Neoplasm Proteins; 0 / ORAI1 protein, human; 0 / Orai1 protein, rat; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / STIM1 protein, human; 0 / Stim1 protein, rat; 0 / TRPC Cation Channels; 0 / transient receptor potential cation channel, subfamily C, member 1; 67526-95-8 / Thapsigargin; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ NIHMS85575; NLM/ PMC2682347
  •  go-up   go-down


95. Yamada P, Isoda H, Han JK, Talorete TP, Abe Y: Inhibitory effect of fulvic acid extracted from Canadian sphagnum peat on chemical mediator release by RBL-2H3 and KU812 cells. Biosci Biotechnol Biochem; 2007 May;71(5):1294-305
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the antiallergic effect of CP-FA, we incubated rat basophilic leukemia (RBL-2H3) cells with 0.001-10.0 microg/ml of CP-FA and determined the beta-hexosaminidase release inhibition at different response stages.
  • [MeSH-minor] Animals. Antigen-Antibody Complex / immunology. Antigens / immunology. Calcimycin / pharmacology. Calcium / analysis. Cell Line, Tumor. Dose-Response Relationship, Drug. Fluorescent Dyes. Formazans / metabolism. Humans. Immunoglobulin E / pharmacology. Ionophores / pharmacology. Leukemia, Basophilic, Acute. Leukemia, Experimental. Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Nuclear Magnetic Resonance, Biomolecular. Rats. Spectroscopy, Fourier Transform Infrared. Tetradecanoylphorbol Acetate / pharmacology. Tetrazolium Salts / metabolism. beta-N-Acetylhexosaminidases / antagonists & inhibitors. p-Methoxy-N-methylphenethylamine / pharmacology

  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Biosci Biotechnol Biochem. 2008 Oct;72(10):2008E4
  • (PMID = 17485833.001).
  • [ISSN] 0916-8451
  • [Journal-full-title] Bioscience, biotechnology, and biochemistry
  • [ISO-abbreviation] Biosci. Biotechnol. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Antigen-Antibody Complex; 0 / Antigens; 0 / Benzopyrans; 0 / Fluorescent Dyes; 0 / Formazans; 0 / Ionophores; 0 / Plant Extracts; 0 / Tetrazolium Salts; 23305-68-2 / MTT formazan; 37341-29-0 / Immunoglobulin E; 37H9VM9WZL / Calcimycin; 4091-50-3 / p-Methoxy-N-methylphenethylamine; EC 3.2.1.52 / beta-N-Acetylhexosaminidases; NI40JAQ945 / Tetradecanoylphorbol Acetate; SY7Q814VUP / Calcium; XII14C5FXV / fulvic acid
  •  go-up   go-down


96. Brink DS: Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome. Adv Anat Pathol; 2006 Sep;13(5):256-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
  • Transient leukemia of Down syndrome (DS-TL), also known as transient myeloproliferative disorder of Down syndrome (DS) and transient abnormal myelopoiesis of DS, occurs in approximately 10% of DS neonates and in phenotypically normal neonates with trisomy 21 mosaicism.
  • Bone marrow characteristics of DS-TL are, likewise, variable, though (in contrast to other leukemias) the bone marrow blast differential can be lower than the peripheral blood blast differential.
  • Despite its typical transient nature, 20% to 30% of DS-TL patients develop overt (nontransient) acute leukemia, usually within 3 years and typically of the M7 phenotype (acute megakaryoblastic leukemia).
  • The pathogenesis of DS-TL (and of subsequent acute leukemia) involves mutation of GATA1 (on chromosome X), which normally encodes a transcription factor integral to normal development of erythroid, megakaryocytic, and basophilic/mast cell lines.
  • [MeSH-minor] GATA1 Transcription Factor / genetics. Humans. Hydrops Fetalis / etiology. Infant, Newborn. Leukemia / etiology. Liver Diseases / etiology. Mutation

  • Genetic Alliance. consumer health - Down Syndrome.
  • MedlinePlus Health Information. consumer health - Down Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16998319.001).
  • [ISSN] 1072-4109
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / GATA1 Transcription Factor; 0 / GATA1 protein, human
  • [Number-of-references] 81
  •  go-up   go-down


97. Passante E, Ehrhardt C, Sheridan H, Frankish N: In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds. Inflamm Res; 2008;57 Suppl 1:S15-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.
  • [MeSH-major] Cell Degranulation / drug effects. Histamine Release / drug effects. Indenes / pharmacology. Leukemia, Basophilic, Acute / immunology. Mast Cells / drug effects

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. QUERCETIN .
  • Hazardous Substances Data Bank. TERFENADINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18345510.001).
  • [ISSN] 1023-3830
  • [Journal-full-title] Inflammation research : official journal of the European Histamine Research Society ... [et al.]
  • [ISO-abbreviation] Inflamm. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Histamine H1 Antagonists, Non-Sedating; 0 / Indenes; 7BA5G9Y06Q / Terfenadine; 9IKM0I5T1E / Quercetin; EC 3.2.1.52 / beta-N-Acetylhexosaminidases
  •  go-up   go-down


98. Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S: Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol; 2009 Aug;40(8):1194-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm.
  • Chronic basophilic leukemia is a rare and poorly characterized entity.
  • [MeSH-major] Basophils / pathology. Leukemia, Myeloid, Chronic-Phase / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19427022.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ETS translocation variant 6 protein; 0 / Proto-Oncogene Proteins c-ets; 0 / Repressor Proteins
  •  go-up   go-down


99. Baik SY, Jung KH, Choi MR, Yang BH, Kim SH, Lee JS, Oh DY, Choi IG, Chung H, Chai YG: Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neurosci Lett; 2005 Feb 1;374(1):53-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] 14-3-3 Proteins / metabolism. Fluoxetine / pharmacology. Leukemia, Basophilic, Acute / metabolism. Tryptophan Hydroxylase / metabolism

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15631896.001).
  • [ISSN] 0304-3940
  • [Journal-full-title] Neuroscience letters
  • [ISO-abbreviation] Neurosci. Lett.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / 14-3-3 Proteins; 0 / Antidepressive Agents, Second-Generation; 01K63SUP8D / Fluoxetine; EC 1.14.16.4 / Tryptophan Hydroxylase
  •  go-up   go-down


100. Hanashiro K, Sunagawa M, Nakasone T, Nakamura M, Kosugi T: Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs. Int Immunopharmacol; 2007 Jul;7(7):994-1002
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs.
  • We examined the effect of antiallergic drugs, azelastine and epinastine, on the expression of FcepsilonRIalpha, beta, and gamma chains and phosphorylation of the gamma chains in rat basophilic leukemia (RBL-2H3) cells.
  • [MeSH-major] Anti-Allergic Agents / pharmacology. Dibenzazepines / pharmacology. Imidazoles / pharmacology. Immunoglobulin E / metabolism. Leukemia, Basophilic, Acute / metabolism. Phthalazines / pharmacology. Receptors, IgE / drug effects. Receptors, IgE / metabolism

  • Hazardous Substances Data Bank. Azelastine .
  • Hazardous Substances Data Bank. L-TYROSINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17499203.001).
  • [ISSN] 1567-5769
  • [Journal-full-title] International immunopharmacology
  • [ISO-abbreviation] Int. Immunopharmacol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Allergic Agents; 0 / Dibenzazepines; 0 / Imidazoles; 0 / Phthalazines; 0 / Receptors, IgE; 37341-29-0 / Immunoglobulin E; 42HK56048U / Tyrosine; Q13WX941EF / epinastine; ZQI909440X / azelastine
  •  go-up   go-down






Advertisement